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1. Summary 
Development of the central nervous system in Drosophila melanogaster relies on neural stem 
cells called neuroblasts. Neuroblasts divide asymmetrically to give rise to a new neuroblast as 
well as a small daughter cell which eventually generates neurons or glia cells. Between each 
division, neuroblasts have to re-grow to be able to divide again. In previous studies, it was 
shown that neuroblast proliferation, cell size and the number of progeny cells is negatively 
affected in larvae carrying a P-element induced disruption of the gene mushroom body 
miniature (mbm). This mbm null mutation called mbmSH1819 is homozygously lethal during 
pupation. It was furthermore shown that the nucleolar protein Mbm plays a role in the 
processing of ribosomal RNA (rRNA) as well as the translocation of ribosomal protein S6 
(RpS6) in neuroblasts and that it is a transcriptional target of Myc. Therefore, it was suggested 
that Mbm might regulate neuroblast proliferation through a role in ribosome biogenesis. 
In the present study, it was attempted to further elucidate these proposed roles of Mbm and to 
identify the protein domains that are important for those functions. Mbm contains an 
arginine/glycine rich region in which a di-RG as well as a di-RGG motif could be found. 
Together, these two motifs were defined as Mbm’s RGG-box. RGG-boxes can be found in 
many proteins of different families and they can either promote or inhibit protein-RNA as 
well as protein-protein interactions. Therefore, Mbm’s RGG-box is a likely candidate for a 
domain involved in rRNA binding and RpS6 translocation. It could be shown by deletion of 
the RGG-box, that MbmdRGG is unable to fully rescue survivability and neuroblast cell size 
defects of the null mutation mbmSH1819. Furthermore, Mbm does indeed rely on its RGG-box 
for the binding of rRNA in vitro and in mbmdRGG as well as mbmSH1819 mutants RpS6 is 
partially delocalized. Mbm itself also seems to depend on the RGG-box for correct 
localization since MbmdRGG is partially delocalized to the nucleus. Interestingly, protein 
synthesis rates are increased in mbmdRGG mutants, possibly induced by an increase in TOR 
expression. Therefore, Mbm might possess a promoting function in TOR signaling in certain 
conditions, which is regulated by its RGG-box. Moreover, RGG-boxes often rely on 
methylation by protein arginine methyltransferases (in Drosophila: Darts – Drosophila 
arginine methyltransferases) to fulfill their functions. Mbm might be symmetrically 
dimethylated within its RGG-box, but the results are very equivocal. In any case, Dart1 and 
Dart5 do not seem to be capable of Mbm methylation. 
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Additionally, Mbm contains two C2HC type zinc-finger motifs, which could be involved in 
rRNA binding. In an earlier study, it was shown that the mutation of the zinc-fingers, mbmZnF, 
does not lead to changes in neuroblast cell size, but that MbmZnF is delocalized to the 
cytoplasm. In the present study, mbmZnF mutants were included in most experiments. The 
results, however, are puzzling since mbmZnF mutant larvae exhibit an even lower viability than 
the mbm null mutants and MbmZnF shows stronger binding to rRNA than wild-type Mbm. 
This suggests an unspecific interaction of MbmZnF with either another protein, DNA or RNA, 
possibly leading to a dominant negative effect by disturbing other interaction partners. 
Therefore, it is difficult to draw conclusions about the zinc-fingers’ functions. 
In summary, this study provides further evidence that Mbm is involved in neuroblast 
proliferation as well as the regulation of ribosome biogenesis and that Mbm relies on its 
RGG-box to fulfill its functions. 
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2. Zusammenfassung 
Die Entwicklung des zentralen Nervensystems von Drosophila melanogaster beruht auf 
neuronalen Stammzellen genannt Neuroblasten. Neuroblasten teilen sich asymmetrisch und 
bringen dabei sowohl einen neuen Neuroblasten als auch eine kleinere Tochterzelle hervor, 
die wiederum letztlich Neuronen oder Gliazellen generiert. Zwischen jeder Zellteilung 
müssen die Neuroblasten wieder auf ihre ursprüngliche Größe wachsen, sodass sie zur 
erneuten Teilung in der Lage sind. In vorhergehenden Studien konnte gezeigt werden, dass 
sowohl die Proliferation der Neuroblasten, deren Zellgröße als auch die Anzahl ihrer 
Tocherzellen reduziert ist in Larven, die eine P-Element-induzierte Unterbrechung des Gens 
mushroom body miniature (mbm) tragen. Diese mbm-Nullmutation, genannt mbmSH1819, ist 
homozygot letal während des Puppenstadiums. Es konnte außerdem gezeigt werden, dass das 
nucleoläre Protein Mbm eine Rolle in der Prozessierung ribosomaler RNA (rRNA), sowie der 
Translokation des ribosomalen Proteins S6 (RpS6) in Neuroblasten erfüllt und dass seine 
Transkription durch Myc reguliert wird. Daher wurde geschlussfolgert, dass Mbm die 
Proliferation von Neuroblasten durch eine Funktion in der Ribosomenbiogenese regulieren 
könnte. 
In der vorliegenden Studie wurde das Ziel verfolgt, weitere Hinweise auf diese möglichen 
Funktionen von Mbm zu finden und die Proteindomänen zu identifizieren, die dafür benötigt 
werden. Mbm beinhaltet einen Arginin/Glycin-reichen Abschnitt, der ein di-RG sowie ein di-
RGG Motiv enthält. Diese beiden Motive wurden zusammen zu Mbms RGG-Box definiert. 
RGG-Boxen finden sich in vielen Proteinen verschiedener Familien und sie können sich 
sowohl verstärkend als auch inhibierend auf Protein-RNA- sowie Protein-Protein-
Interaktionen auswirken. Somit stellt Mbms RGG-Box einen vielversprechenden Kandidaten 
dar für eine Proteindomäne, die in die rRNA-Bindung sowie die Translokation von RpS6 
involviert ist. Es konnte gezeigt werden, dass Mbm mit deletierter RGG-Box (MbmdRGG) 
nicht in der Lage ist, die Überlebensfähigkeit und die Neuroblastengröße der Nullmutation 
mbmSH1819 vollständig zu retten. Des Weiteren benötigt Mbm die RGG-Box, um rRNA in 
vitro zu binden und in mbmdRGG sowie mbmSH1819 Mutanten konnte eine partielle 
Delokalisation von RpS6 beobachtet werden. Die korrekte Lokalisation von Mbm selbst 
scheint auch von der RGG-Box abzuhängen, da MbmdRGG teilweise in den Nukleus 
delokalisiert ist. Interessanterweise ist außerdem die Proteinsyntheserate in mbmdRGG 
Mutanten erhöht, was möglicherweise in einer Erhöhung der TOR-Expression begründet ist. 
Somit könnte Mbm unter bestimmten Bedingungen eine verstärkende Funktion im TOR-
Zusammenfassung 
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Signalweg erfüllen, die durch seine eigene RGG-Box reguliert wird. Des Weiteren sind RGG-
Boxen hinsichtlich ihrer Funktion häufig von der Methylierung durch Protein-Arginin-
Methyltransferasen (in Drosophila: Darts – Drosophila arginine methyltransferases) 
abhängig. Mbm könnte innerhalb seiner RGG-Box symmetrisch dimethyliert sein, allerdings 
sind die Ergebnisse in dieser Hinsicht sehr zweifelhaft. Jedenfalls scheinen Dart1 und Dart5 
nicht imstande zu sein, Mbm zu methylieren. 
Außerdem beinhaltet Mbm zwei Zink-Finger-Motive des C2HC-Typs, die in die Bindung von 
rRNA involviert sein könnten. Eine vorhergehende Studie konnte zeigen, dass die Mutation 
der Zink-Finger, mbmZnF, zwar nicht zu einer Veränderung der Neuroblastengröße führt, 
allerdings, dass MbmZnF ins Zytoplasma delokalisiert vorliegt. In der vorliegenden Studie 
wurden die mbmZnF Mutanten in die meisten Experimente mit einbezogen. Allerdings sind die 
Ergebnisse rätselhaft, da mbmZnF-mutierte Larven sogar eine geringere Überlebensrate zeigen 
als die mbm Nullmutanten und da MbmZnF eine stärkere Bindungsaffinität zu rRNA zeigt als 
wildtypisches Mbm. Dies weist auf eine unspezifische Interaktion zwischen MbmZnF und 
einem anderen Protein, RNA oder DNA hin, was einen dominant-negativen Effekt auslösen 
könnte, indem andere Interaktionspartner gestört werden. Somit gestaltet es sich schwierig, 
Schlussfolgerungen zur Funktion der Zink-Finger zu ziehen. 
Zusammengefasst liefert die vorliegende Studie weitere Anhaltspunkte, dass Mbm in der 
Neuroblastenproliferation sowie der Regulation der Ribosomenbiogenese involviert ist und 
dass Mbm seine RGG-Box benötigt, um seine Funktionen zu erfüllen. 
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3. Introduction 
3.1. Neurogenesis in Drosophila melanogaster 
Drosophila melanogaster is a widely used model organism for developmental and 
neurobiology research. It found its way into laboratories as early as around 1900 and it has 
since become the number one genetic system due to being easy to maintain and to modify 
genetically (Kohler, 1994; Tolwinski, 2017). Therefore and due to the key features of 
neuronal development of higher species being present in Drosophila, it is a very good model 
organism to study brain development (Homem and Knoblich, 2012). The brain or central 
nervous system (CNS) of Drosophila consists of the central brain (CB), the optic lobes (OL) 
and the ventral nerve cord (VNC). It is built up during neurogenesis in the embryonic and 
larval stages by neural progenitor cells called neuroblasts (NBs). NBs are the neural stem cells 
in Drosophila and are therefore studied to shed light into stem cell biology (Homem & 
Knoblich, 2012). Early during the embryonal development  – between embryonic stages 8 and 
11 – the NBs from which the CB and VNC arise delaminate from the neuro-ectoderm in the 
embryo’s ventrolateral region (Campos-Ortega & Hartenstein, 1997; Homem and Knoblich, 
2012). In the case of the VNC, the NB fate is decided for only one cell in a neural equivalence 
group of 5 to 6 cells (Egger et al., 2008) by a positive feedback loop in Delta/Notch signaling 
and expression of achaete-scute (ac/sc) genes. ac/sc genes which promote the NB fate 
(Villares and Cabrera, 1987; Gonzalez et al., 1989) induce Delta signaling to neighboring 
cells, thereby activating Notch which leads to ac/sc down-regulation in these cells and 
induction of the epidermal cell fate (Skeath and Carroll, 1992). Thus, the cell that initially 
exhibits the highest ac/sc expression levels within an equivalence group will acquire the NB 
cell fate (Martin-Bermudo et al., 1991; Cubas et al., 1991; Skeath and Carroll, 1991; reviewed 
in Skeath and Thor, 2003; Figure 1). Approximately 50 % of NBs, however, lack ac/sc 
function meaning that other NB cell fate determinants must exist (Jimenez and Campos-
Ortega, 1990) with seven-up and huckebein being potential candidates (Doe, 1992). 
In the case of the central brain, NB delamination is more complex. The procephalic 
neuroectoderm is divided into several mitotic domains within which the cell cycle entry of all 
cells is synchronized (Foe, 1989). These mitotic domains also exhibit different modes of NB 
delamination (Urbach et al., 2003; Urbach and Technau, 2004). In mitotic domain B, instead 
of producing NBs by division, neuroectodermal cells enlarge on the basal side and then 
delaminate as NBs (Figure 2A). In mitotic domains 1, 2 and 5, cells divide in parallel to the 
ectodermal layer and then one of the daughter cells delaminates as a NB (Figure 2B). In 
Introduction 
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mitotic domain 9, there are two different modes of NB formation. In one case, 
neuroectodermal cells delaminate from the layer in apical direction, then reintegrate and either 
delaminate in basal direction as NBs or remain in the layer as epidermoblasts (Figure 2Ca). In 
the other case, the cells divide along the apical-basal axis with the basal daughter cell 
becoming a NB while the apical daughter cell integrates into the ectodermal layer as an 
epidermoblast (Figure 2Cb; Urbach et al., 2003; Urbach and Technau, 2004). Like in the 
VNC, the NB fate is decided in cell clusters which express proneural genes of the ac/sc group, 
but these clusters significantly vary in size. While the small clusters of five to seven cells only 
produce one NB similar to the clusters in the VNC, in the larger clusters several adjacent cells 
can adopt the NB fate due to less efficient lateral inhibition by Delta/Notch signaling (Urbach 
et al., 2003). Unlike CB and VNC neuroblasts, the ~800 OL NBs were long believed to arise 
from neuroepithelial cells during larval stages only (Egger et al., 2007; Harding and White, 
2018). Newer results, however, show that OL NBs are already generated by the 
neuroepithelium during embryonic stages (Hakes et al., 2018). In mid-larval stages, the 
neuroepithelial cells then transform into OL NBs (Yasugi et al., 2008). 
After delamination, the NBs start to divide in a self-renewing manner (Reichert, 2011), 
generating a new NB as well as ganglion mother cells (GMC) or intermediate neural 
progenitors (INP) which in the end generate neurons or glia cells (reviewed in Homem and 
Knoblich, 2012). This phase in brain development is known as the first wave of neurogenesis 
during which all cells composing the larval CNS, but only about 10 % of the adult CNS are 
generated (Prokop and Technau, 1991; Green et al., 1993; Homem and Knoblich, 2012). In 
the embryonic stages, the NBs do not regrow between each division and therefore become 
Figure 1: Neuroblast cell fate decision 
In a neural equivalence group, achaete-scute (ac/sc) genes are at first approximately evenly expressed (orange). 
The cell with the highest ac/sc expression laterally inhibits ac/sc expression in the other cells of the group 
through Delta/Notch signaling (yellow) and becomes the only neuroblast of the cell cluster (figure modified 
from Skeath and Thor (2003) with permission from Elsevier). 
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progressively smaller until they enter a quiescent state or undergo apoptosis before larval 
hatching (Figure 3). Quiescence might be initiated by the reduction in NB cell size between 
each division (Hartenstein et al., 1987) and apoptosis is induced by the reaper gene (Peterson 
et al., 2002). A newer study could show that NB quiescence is initiated by a pulse of transient 
nuclear Prospero, a protein that is otherwise known as a cell fate determinant in asymmetric 
NB division (see 3.1.2.), but the exact mechanism remains unclear (Lai and Doe, 2014; 
Harding and White, 2018). The ratio of NBs entering quiescence versus those undergoing 
programmed cell death differs between embryonal segments: out of 30 abdominal NBs only 
three enter quiescence while 20 out of 30 thoracic NBs persist into the larval stages (Truman 
and Bate, 1988; Prokop and Technau, 1991; White et al., 1994). Recently, it was shown that 
75 % of NBs enter quiescence during the G2 phase of the cell cycle while the remaining 25 % 
exit the cell cycle in G0 phase (Otsuki and Brand, 2018). Entry into G2 quiescence as well as 
maintaining the quiescent state into larval stages is regulated by the pseudokinase tribbles. 
Furthermore, it was found that NBs in G2 quiescence are reactivated more quickly than those 
in G0 quiescence which might be important for producing neural circuits in the correct order 
(Otsuki and Brand, 2018). The NBs re-enter the cell cycle after larval hatching (ALH), 
starting the second wave of neurogenesis during which the remaining 90 % of the CNS are 
generated. The exact point in time at which the NBs re-enter the cell cycle differs between 
tissues with CB NBs starting between eight and ten hours ALH, followed by OL NBs after ten 
to twelve hours, the thoracic NBs after 28 hours and the abdominal NBs ~50 hours ALH 
Figure 2: Neuroblast formation in the procephalic neuroectoderm 
NB formation differs between mitotic domains. A In domain B, neuroectodermal cells enlarge on the apical side 
and delaminate as NBs. The scheme on the left shows the positions of the mitotic domains in the procephalic 
ectoderm in lateral view. B In domains 1, 2 and 5, the ectodermal cells divide parallel to the layer and one 
daughter cell delaminates as a NB. C In mitotic domain 9, two modes of NB formation can occur.                   
Ca) Neuroectodermal cells move to the apical side, then re-enter the layer and either delaminate as a NB or stay 
as an epidermoblast (EB). Cb) Neuroectodermal cells divide along the apical-basal axis. The apical daughter cell 
re-enters the layer as an EB, the basal progeny delaminates as a NB (figure modified from Urbach et al. (2003) 
with permission from The Company of Biologists Ltd.). 
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(Truman and Bate, 1988; Prokop and Technau, 1991; Ebens et al., 1993; Green et al., 1993; 
Datta, 1995; Sousa-Nunes et al., 2011). Cell cycle re-entry depends on nutrient sensing 
pathways and does not occur under lack of amino acid intake (Sousa-Nunes et al., 2011; Chell 
and Brand, 2010; Harding and White, 2018). Glia cells in close proximity to the neuroblasts 
regulate NB reactivation through secretion of insulin-like peptides 2/6 (dILP2/6), thereby 
initiating cell cycle re-entry through Akt signaling (Chell and Brand, 2010). However, it was 
noted that dILP2/6 secretion alone is not sufficient for full NB reactivation. It was 
furthermore shown that glial cells regulate NB quiescence and proliferation through secretion 
of anachronism, terribly reduced optic lobes and dally-like, but the respective mechanisms 
remain unclear (Ebens et al., 1993; Datta, 1995; Voigt et al., 2002; Kanai et al., 2018; Harding 
and White, 2018). Following reactivation, NBs regrow between each division, which enables 
them to divide more often. During the pupal stages, however, the NBs become smaller once 
again and while abdominal NBs eventually are eliminated by apoptosis through expression of 
reaper, grim and sickle, thoracic and CB NBs undergo a final symmetrical division (Ito and 
Hotta, 1992; Maurange et al., 2008; Peterson et al., 2002; Tan et al., 2011 Siegrist et al., 2010; 
Harding and White, 2018; Figure 3). This final differentiation is initiated by the nuclear 
accumulation of Prospero, leading to differentiation by down-regulation of self-renewal genes 
(Maurange et al., 2008; Choksi et al., 2006). 
 
Figure 3: Neurogenesis in Drosophila melanogaster 
During the first wave of neurogenesis in embryonic stages 8 to 11 the neuroblasts (NB) delaminate from the 
neuro-ectoderm and start dividing growing progressively smaller until they undergo apoptosis or enter 
quiescence. Early in the larval stages the NBs re-enter the cell cycle now re-growing between each division. This 
second wave of neurogenesis ends in the pupal stage when NBs become smaller once again and undergo 
apoptosis or final differentiation (figure from Homem & Knoblich (2012) with permission from The Company of 
Biologists Ltd). 
 
Many neuroblast cell fate decisions like apoptosis or final differentiation are regulated by the 
so-called temporal series, which is characterized by sequentially expressed transcription 
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factors (Maurange et al., 2008; Harding and White, 2018). The exact temporal transcription 
factor (TTF) series, however, varies between different NB populations (reviewed in Doe, 
2017). Most embryonic type I NBs, for example, sequentially express Hunchback (Hb) → 
Krüppel (Kr) → Pdm → Castor (Cas) → Grainyhead (Grh) and each of these TTFs specifies 
the identity of NB progeny and thus ensures the generation of the correct neurons in their 
respective time frame (Figure 4). Grh, however, has also been shown to regulate apoptosis as 
well as proliferation of NBs, which might in turn be regulated by Hox genes (Cenci and 
Gould, 2005; Almeida and Bray, 2005; Harding and White, 2018). Furthermore, some of 
these TTFs are repressed by their respective successor in the series: Kr is repressed by Pdm, 
Pdm is repressed by Cas and Cas is repressed by Grh (Grosskortenhaus et al., 2006; Tran and 
Doe, 2008; Kambadur et al., 1998; Tsuji et al., 2008; Baumgardt et al., 2009). Thereby, the 
unidirectional cascade of TTF expression is ensured (Doe, 2017). 
 
Figure 4: The temporal transcription factor (TTF) series 
The TTF expression sequence in embryonic type I neuroblasts (NB). Each TTF specifies the cell fate of the 
progeny in the respective time frame (HB = Hunchback; Kr = Krüppel; Cas = Castor; Grh = Grainyhead; GMC = 
ganglion mother cell). Grainyhead also regulates proliferation and apoptosis in neuroblasts (figure adapted from 
Harding and White (2018), licensed under CC BY 4.0). 
 
 
3.1.1. Neuroblasts in the 3rd instar larval central brain 
In the 3rd instar larval CB there are around 105 neuroblasts per brain hemisphere (Urbach et 
al., 2003; Urbach and Technau, 2003a; Urbach and Technau, 2003b). There are, however, not 
a single but three different types of NBs: approximately 90 type I and eight type II neuroblasts 
which differ in their mode of division (reviewed in Homem and Knoblich, 2012) as well as 
four mushroom body neuroblasts (MBNBs). The MBNBs build up the MB and do not enter 
quiescence between the first and second wave of neurogenesis (Ito and Hotta, 1992; Figure 5). 
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Figure 5: Neuroblasts in the 3rd instar larval 
central brain 
In the 3rd instar larval central brain of 
Drosophila there are approximately 90 type I 
NBs (yellow), eight type II NBs (green) and 
four mushroom body (MB) NBs (purple) per 
hemisphere. The type I NBs directly give rise to 
ganglion mother cells (GMC; orange), while 
type II NBs produce intermediate neural 
progenitors (INP; ocher) which then generate 
GMCs. CNS: central nervous system; VNC: 
ventral nerve cord; OL: optic lobe (figure 
modified from Homem & Knoblich (2012) with 
permission from The Company of Biologists 
Ltd). 
 
 
Type I NBs divide asymmetrically into a new neuroblast and a ganglion mother cell (GMC). 
Type II NBs, in contrast, divide into a new NB and an immature intermediate neural 
progenitor (INP). The immature INP then matures by changes in gene transcription and divide 
asymmetrically for three to five times (Bello et al., 2008), generating a new INP as well as a 
GMC. The GMCs in both the type I and type II NB lineages divide symmetrically into two 
neurons or glia cells (Homem & Knoblich, 2012; Figure 6). Thereby, each type II NB on 
average generates 450 neural cells while type I NB lineages comprise only about 100 to 120 
neural cells on average (Izergina et al., 2009; Bello et al., 2008). However, there is an 
additional mode of NB division in the embryonic VNC, leaving out the GMC intermediate: 
type 0 NBs divide into a new NB and a terminally differentiated neuron (Baumgardt et al., 
2014; Karcavich and Doe, 2005, Baumgardt et al., 2009). Type 0 NBs previously divide in 
type I mode and then undergo a switch to type 0, which is suggested to be regulated by the 
temporal series (Harding and White, 2018).  
Type I and type II NB lineages can be distinguished by several differentially expressed 
transcription factors (Figure 6). Both NB types express Deadpan (Dpn) which plays an 
important role in self-renewing neural precursors in Drosophila (Homem and Knoblich, 2012; 
Wallace et al., 2000), but only type I NBs express Asense (Ase; Bowman et al., 2008). In type 
II NBs, Ase expression is assumed to be suppressed by an isoform of Pointed (PntP1) which 
induces the type II NB cell fate and therefore is absent in type I NBs (Zhu et al., 2011). 
Furthermore, it was recently shown that PntP1 and other components of the epidermal growth 
factor (EGF) signaling pathway are also required for the specification of type II NBs during 
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embryogenesis (Walsh and Doe, 2017; Alvarez and Diaz-Benjumea, 2018; Harding and 
White, 2018). In contrast to NBs, immature INPs lack both Ase as well as Dpn. During 
maturation, which takes four to six hours, INPs do not divide but re-start expression of Ase 
and Dpn and then start dividing asymmetrically (Bayraktar et al., 2010). Furthermore, 
maturing INPs start to express Earmuff (Erm) which is suggested to limit proliferation and 
eventually promote terminal differentiation of INPs (Li et al., 2016; Homem and Knoblich, 
2012; Weng et al., 2010). Both the type I NBs and the INPs in the type II NB lineage give rise 
to GMCs which lack expression of all the transcription factors mentioned above (Bayraktar et 
al., 2010). In summary, type I NBs are Dpn+, Ase+, Erm- and PntP1-, type II NBs are Dpn+, 
Ase-, Erm- and PntP1+, only mature INPs are Dpn+, Ase+ and Erm+ and GMCs show no 
expression of these transcription factors (Figure 6). 
 
 
Figure 6: Type I and type II neuroblast lineages 
A Type I neuroblasts (NBs) are Dpn+ (red) and Ase+ (green) and divide asymmetrically into a new NB and a 
ganglion mother cell (GMC; light grey) which divides symmetrically into neurons or glia cells (dark grey).        
B Type II NBs are Dpn+ (red) and PntP1+ (blue) and divide symmetrically into a new NB and an immature 
intermediate neural progenitor (INP; yellow) which then matures and expresses Dpn (red), Ase (green) as well as 
Erm (purple). Mature INPs divide asymmetrically to self-renew and produce a GMC (light gray) which divides 
symmetrically into neurons or glia cells (dark grey). The coloring of NBs and INPs does not indicate polarized 
localization of the mentioned transcription factors (figure adapted from Homem & Knoblich (2012) with 
permission from The Company of Biologists Ltd). 
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3.1.2. Asymmetric division of neuroblasts 
Self-renewing asymmetric division and the generation of all cell types in their respective 
tissue is a feature characteristic for stem cells (Hall and Watt, 1989; Potten and Loeffler, 
1990; Morrison et al., 1997). As mentioned earlier, neuroblasts are the neural stem cells in 
Drosophila and are being used as a model to study stem cell biology (Homem & Knoblich, 
2012). In contrast to germline stem cells, for example, the asymmetric division of NBs does 
not depend on extrinsic signals or an external axis and they are therefore capable of self-
renewing asymmetric divisions even in cell culture (Homem & Knoblich, 2012; Datta, 1999; 
Ceron et al., 2006; Rebollo et al., 2007). However, the correct orientation of the cortical 
polarity relative to the neuroepithelium was shown to depend on extrinsic signaling in 
embryonic NBs (Siegrist and Doe, 2006; Yoshiura et al., 2012). The intrinsic signals defining 
the apical-basal axis and inducing asymmetric divisions are conducted by several protein 
complexes and cell fate determinants (Figure 7).  
 
 
Figure 7: Asymmetric division of neuroblasts 
Asymmetric division of neuroblasts is induced by protein complexes on the apical side of the cell. The Par 
complex (Bazooka (Baz), atypical protein kinase C (aPKC) and Par6; yellow) directs the cell fate determinants 
Prospero (Pros), Brat (Brain tumor) and Numb as well as their adaptor proteins Miranda (Mira) and Partner of 
Numb (Pon; magenta) to the basal side where they are segregated into the small daughter cell and lead to the 
ganglion mother cell (GMC) fate. The other protein complex consisting of Inscuteable (Insc), Partner of 
Inscuteable (Pins), Loco and Gαi recruits Mud, which attracts one of the spindle poles to the apical side. In a 
second pathway, Pins recruits Dlg and Khc-73, which links astral microtubules to the apical cortex. A: apical,   
B: basal (figure modified from Egger et al. (2008), licensed under CC BY 4.0). 
 
The apical-basal axis of NBs is inherited from the epithelial cells during delamination in the 
embryonic stages by retaining the apical localization of the Par complex (Schober et al., 1999; 
Wodarz et al., 1999; Homem & Knoblich, 2012). This complex consists of the proteins 
Bazooka (Baz), Par6 and atypical protein kinase C (aPKC; Betschinger and Knoblich, 2004). 
The Par complex then recruits Inscuteable (Insc) which binds to Baz and in turn recruits 
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Partner of Inscuteable (Pins). Pins contains three GoLoco domains which bind to the 
heterotrimeric G protein subunit Gαi (Knoblich, 2008). This induces a conformational change 
of Pins leading to recruitment of Mud which in turn is capable of binding microtubules and 
attracting one of the spindle poles to the apical side (Bowman et al., 2006; Knoblich, 2008; 
Dewey et al., 2016). There is, however, a second pathway of spindle orientation in which Pins 
binds to Discs Large (Dlg), which subsequently recruits kinesin motor protein Khc-73.     
Khc-73 is capable of binding the plus ends of microtubules and therefore, the complex                   
Pins – Dlg – Khc-73 is suggested to link astral microtubules to the apical cortex (Siegrist and 
Doe, 2005; Gallaud et al., 2017). 
Following the initial asymmetric division, the apical localization of the Par complex and its 
partners and consequently the spindle orientation is setup during interphase. The basal 
localization of cell fate determinants (CFDs) that are segregated into the small daughter cell, 
however, takes place during metaphase. An important factor for the basal localization of 
CFDs is Lethal (2) of giant larvae (Lgl; Peng et al., 2000; Ohshiro et al., 2000), which is 
phosphorylated by aPKC (Plant et al., 2003; Yamanaka et al., 2003; Betschinger et al., 2003). 
Since aPKC localization is restricted to the apical side and overexpression of aPKC leads to 
loss of function of lgl, it is suggested that Lgl is inactivated by aPKC-mediated 
physphorylation and is therefore only active on the basal side of the NB (Betschinger et al., 
2005; Knoblich, 2008). However, it is not known how Lgl is essential for CFD localization, 
especially since none of the CFDs bind to Lgl (Knoblich, 2008). 
The cell fate determinants that are segregated into the small daughter cell inducing the GMC 
fate are Numb, Prospero (Pros) and Brain tumor (Brat) (Spana et al., 1995; Hirata et al., 1995; 
Bello et al., 2006). Numb binds to the endocytic protein α-Adaptin and thereby represses 
signal transduction in the Notch pathway (Berdnik et al., 2002; Le Borgne et al., 2005; 
Schweisguth, 2004). Upon Numb mutation, NBs show a tumor-like phenotype (Lee et al., 
2006a; Wang et al., 2006) caused by NB-specific gene expression and proliferation pattern in 
both daughter cells (Knoblich, 2008). Similarly, mutation of Pros leads to the expression of 
NB markers and multiple divisions of GMCs in the embryo (Choksi et al., 2006) and to tumor 
formation in larval NBs (Betschinger et al., 2006; Lee et al., 2006b; Bello et al., 2006). Pros is 
nuclear only in GMCs (Betschinger and Knoblich, 2004) where it acts as a transcription factor 
regulating over 700 genes including cell cycle related and pro-neural genes (Knoblich, 2008; 
Choksi et al., 2006; Southall and Brand, 2009). The third important cell fate determinant, 
Brat, interacts with Pros during embryogenesis to induce GMC formation, but while the single 
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mutation of pros only affects a small portion of GMCs they are almost completely lost in 
pros/brat double mutants (Betschinger et al., 2006). In larval type II NB lineages, Brat binds 
to Deadpan and Zelda in the small daughter cell and mediates their degradation, thereby 
inducing the INP cell fate (Reichardt et al., 2018). Brat loss of function therefore leads to 
formation of multiple type II NB-like cells and tumor formation. However, type II NBs lack 
Pros and are therefore more sensitive to loss of tumor suppressors. Interestingly, 
overexpression of Pros reverts the brat mutant phenotype (Knoblich, 2008). 
Numb, Pros and Brat are segregated to the basal side by the adaptor proteins Partner of Numb 
(Pon) and Miranda (Mira) (Betschinger and Knoblich, 2004). Pon binds to Numb and 
mediates its basal localization. In Pon mutants, however, the asymmetric localization of 
Numb is only delayed to anaphase and telophase, meaning that other factors have to be 
involved (Knoblich, 2008). Yet, delayed segregation of Numb causes defects in NB self-
renewal (Wang et al., 2007). Pros and Brat on the other hand bind to Mira which mediates 
their segregation to the basal side. Mira is furthermore capable of binding Staufen, a protein 
that can bind and transport pros RNA. Loss of Staufen, however, does not influence the 
induction of the GMC cell fate. In mira mutants, in contrast, Pros and Brat localization is 
defective leading to a uniformly cytoplasmic dispersion and therefore an equal segregation 
into both daughter cells (Knoblich, 2008). 
Interestingly, NBs in the inner proliferating center of larval optic lobes were recently shown 
to switch to symmetric amplifying divisions in a temporal pattern (Mora et al., 2018). In these 
cells, the cell fate determinants Numb, Pros and Brat are no longer segregated asymmetrically 
and thus do not lead to asymmetric division. This temporal switch is induced by the pro-
neural gene atonal, but the exact mechanism of the induction of symmetric divisions is still 
unclear (Mora et al., 2018; Harding and White, 2018). 
 
3.2. Mushroom body miniature 
In Drosophila melanogaster there are several known genes which, when mutated, negatively 
influence the development of the CNS or certain brain structures. One of these genes is 
mushroom body miniature (mbm) which was found in a genetic screen of mutant flies 
exhibiting defects in the neuropil known as mushroom body (MB) (Heisenberg et al., 1985). 
The MB is built up by the four equipotent MBNBs and consists of about 2000 intrinsic MB 
neurons per brain hemisphere, the Kenyon cells (Ito and Hotta, 1992; Aso et al., 2009). The 
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Kenyon cells (KC) form the different substructures of the MB: the calyx, which consists of 
dendrites of the cell bodies at the dorsal posterior surface, and the peduncle, which is formed 
by axons projecting ventrally toward the anterior end of the brain (Figure 8 A, B; Lee et al., 
1999). The peduncle bifurcates into five terminal lobes, the γ-, α’/β’- and α/β-neurons   
(Figure 8 C, D), which are born in this order throughout development (Crittenden et al., 1998; 
Jefferis et al., 2002; Lee et al., 1999). The γ-neurons arise during early larval stages while 
α’/β’-neurons are born during the second half of the 3rd instar larval stage and lastly the α/β-
neurons arise during pupal stages (Lee et al., 1999). The larval γ-neurons bifurcate toward the 
medial and dorsal lobe, but then undergo extensive remodeling during the pupal stages 
resulting in the branching pattern of the adult MB (Technau and Heisenberg, 1982; Lee et al., 
1999; Yu and Schuldiner, 2014). Then, the γ-neurons only project toward the medial lobe, 
while the α’/β’- and α/β-neurons bifurcate toward the dorsal surface (α, α’) as well as the 
medial lobe (β, β’) (Crittenden et al., 1998; Ito et al., 1998; Aso et al., 2009). 
 
Figure 8: Mushroom bodies in wild-type and mbm1 mutant female flies 
Cross-sections through wild-type (A – D) and mbm1 (E – H) female fly brains. In mbm1, all compartments (α, α’, 
β, β’ and γ lobes as well as the calyx (ca) and peduncle (ped)) of the mushroom bodies (MB) are still present but 
grossly reduced compared to wild-type flies (figure modified from Raabe et al. (2004); Copyright (2004) 
National Academy of Sciences). 
 
In female flies carrying the hypomorphic mutation mbm1, the MB is greatly reduced (Figure 
8) and the flies show reduced odor-learning capabilities (Heisenberg et al., 1985; Raabe et al., 
2004; de Belle and Heisenberg, 1996). This is consistent with additional findings that the 
mushroom body is involved in olfactory learning and memory (Zars et al., 2000; reviewed in 
Cognigni et al., 2018), besides other functions including control of locomotor activity and 
courtship behavior (Heisenberg, 2003; Ferveur et al., 1995; O'Dell et al., 1995). The reason 
for the sexual dimorphism in mbm1 flies is not known so far. In contrast, the homozygous 
mbm null mutation called mbmSH1819, in which mbm is disrupted by a P-element insertion, is 
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lethal after pupation in both female and male flies. However, the exact role of Mbm remains 
elusive. 
Even though the effect of the mbm1 mutation is observed in the mushroom bodies, mbm 
expression is not exclusive to MBNBs, but Mbm can be found in all NB types. Furthermore, 
in mbmSH1819 mutant 3rd instar larvae the whole brain is visibly smaller than in wild-type. As 
Hovhanyan et al. (2014) could show, Mbm localizes to the nucleolus during interphase and its 
absence (in mbmSH1819 mutant larval brains) leads to a decrease in NB cell size and fewer 
progeny cells. The asymmetric division of NBs, however, is not affected. It was suggested 
that Mbm plays a role in NB proliferation, supported by results showing effects on the 
localization of ribosomal protein S6 (RpS6) and defects in rRNA processing as well as 
decreased protein synthesis rates in mbmSH1819 mutant NBs. It was furthermore shown that 
mbm expression is regulated by dMyc (Hovhanyan et al., 2014) which is known to be 
involved in the expression of ribosome modifying enzymes and ribosomal components 
(Gallant, 2013; Teleman et al., 2008; Li et al., 2010). 
Since Mbm features two C2HC zinc-finger motifs, it was suggested that Mbm might have a 
function involving the binding of nucleic acids (Raabe et al., 2004; Figure 9). In conjunction 
with Mbm’s possible role in rRNA processing, the question arose whether these zinc-fingers 
enable Mbm to bind ribosomal RNA. First experiments showed that Mbm does indeed bind to 
rRNA and DNA, however independent of the two zinc-fingers (Cornelia Engert, Master 
Thesis, 2015). Thus, there has to be another protein domain with the ability to bind nucleic 
acids. In Mbm’s N-terminal half there is an arginine/glycine (R/G) rich region (Figure 9) 
which might contain an RG/RGG-box and thus another possible nucleic acid binding domain 
(see 3.3.). The acidic clusters 1 (AC-1) and 2 (AC-2) shown in Figure 9 contain 
phosphorylation sites for casein kinase 2 (CK2). Mutation of these sites leads to a decrease in 
overall phosphorylation of Mbm and a partial delocalization to the cytoplasm can be observed 
(Hovhanyan et al., 2014). AC-3 was suggested to contain additional CK2 phospho sites, but 
so far, no experimental evidence exists. 
 
Figure 9: Features of the Mbm protein 
Mbm features three clusters of acidic amino acids (AC1-3, orange) which contain phosphorylation sites for 
casein kinase 2 as well as two basic clusters (BC1/2, blue). The two zinc-finger domains (ZnF1/2, green) could 
not be shown to play a role in nucleic acid binding. Two arginine/glycine rich regions (R/G, red) may contain 
RNA binding RG or RGG domains (figure adapted from Anna Hovhanyan, PhD Thesis, 2014). 
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In summary, Mbm is a transcriptional target of dMyc and gets phosphorylated by CK2 and 
might therefore be involved in ribosome biogenesis (Hovhanyan et al., 2014). CK2 is known 
to phosphorylate proteins involved in ribosome biogenesis (e.g. B23; Louvet et al., 2006; 
Negi and Olson, 2006; Szebeni et al., 2003) as well as components of the rRNA transcription 
machinery (Filhol and Cochet, 2009; St-Denis and Litchfield, 2009). Mbm’s relation with 
dMyc furthermore implies a possible role in growth control mediated by the TOR pathway 
(Hovhanyan et al., 2014; Sousa-Nunes et al., 2011). While loss of Mbm leads to NB cell size 
decrease, fewer progeny, delocalization of RpS6 and defective rRNA processing, its exact 
function remains elusive. The idea that Mbm might bind to DNA or rRNA could be 
confirmed, but the zinc-finger domains are not involved. Thus, a potential RG or RGG 
domain in the arginine/glycine rich region would be a promising candidate. 
 
3.3. RGG/RG-boxes and their RNA binding capabilities 
The RGG motif was first described by Lischwe et al., 1985 as a binding site for protein 
arginine methyltransferases (PRMTs) leading to the dimethylation of the domain’s arginines. 
Seven years later, the RNA binding capabilities of RGG motifs were found in the case of 
heterogenous nuclear ribonucleoprotein U (hnRNP U) (Kiledjian and Dreyfuss, 1992). They 
found a sequence of three arginine-glycine-glycine (RGG) repeats in close proximity, which 
is conserved in RNA binding proteins of different species, and named it RGG-box. Some of 
these proteins are mammalian nucleolin (human, mouse and hamster), yeast fibrillarin 1 and 
RNA helicase of fruit flies. However, an extensive study of proteins containing RGG and RG 
repeats revealed that RGG motifs are not constricted to three repeats and that there are also 
cases of tri-RG motifs in proteins involved in RNA biogenesis and mRNA translation 
(Thandapani et al., 2013). In this study, these motifs were defined as follows: tri-RGG motifs 
are three arginine-glycine-glycine repeats separated from each other by 0 – 4 random amino 
acids (Figure 10). Accordingly, the RGG or RG repeats in di-RGG, tri-RG and di-RG motifs 
also have 0 – 4 random amino acids in between. di-RG motifs, however, are very common 
and can be found in many proteins of different families, e.g. in the transcription factor E2F-1, 
in lysine methyltransferase SETD5 or ubiquitin ligase RBBP6. Furthermore, RGG/RG motifs 
often appear in close proximity to each other, possibly functioning together as a motif of a 
higher order (Thandapani et al., 2013). 
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Figure 10: Definition of RGG and RG 
motifs 
RGG and RG motifs are two or three RGG 
(red) or RG (green) repeats separated by 0 – 4 
random amino acids. 
 
 
Besides RNA binding, RGG/RG motifs were also found to be important for protein-protein 
interactions as well as protein localization. For example, RGG/RG motifs are implicated in 
the interaction of nucleolin with the hepatitis C virus protein NS5B or of RNA helicase A 
with β-actin (Kusakawa et al., 2007; Tang et al., 2009). Nucleolin furthermore depends on its 
tri-RGG motif for correct localization to the nucleolus (Ginisty et al., 1999; Pellar and 
DiMario, 2003). Important for RGG/RG motifs’ functions, however, is the methylation status 
of their arginines mediated by PRMTs. 
 
3.3.1. Arginine methylation in RGG/RG motifs 
Posttranslational modification by arginine methylation was shown to be an important 
regulator for protein-protein as well as protein-RNA interactions (Bedford and Clarke, 2009; 
Bedford and Richard, 2005; Bedford, 2007). This is also the case for RGG/RG motifs. For 
example, methylation of the tri-RGG motif in yeast Npl3 inhibits interaction with Tho2 (Yu et 
al., 2004). However, RGG/RG motifs also positively influence protein-protein interactions 
(Cote and Richard, 2005; Friesen et al., 2001; Selenko et al., 2001). Likewise, Blackwell et al. 
(2010) could show that arginine methylation of human FMRP within its RGG-box was 
essential for RNA binding. Furthermore, they found out that methylation of different arginine 
residues was necessary for the binding of different RNA molecules. In contrast, RNA binding 
of human CNBP is inhibited by arginine methylation (Wei et al., 2014). It was suggested that 
the inhibiting effect of arginine methylation on RNA binding might be caused by steric 
hindrance or by the loss of a possible hydrogen bond between the protein and the RNA 
molecule (McBride and Silver, 2001). Promotion of protein-RNA interaction, on the other 
hand, might be induced by the arginine residue becoming more hydrophobic upon 
methylation, thereby facilitating an association (Bedford and Richard, 2005). 
In eukaryotes, arginine methylation is carried out by protein arginine methyltransferases 
(PRMTs). So far, eleven members of the PRMT family have been identified, with PRMT1-9 
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showing methyltransferase activity. PRMTs 10 and 11 are homologs to PRMT 7 and 9, 
respectively, but their functions are still unclear (Harada et al., 2015; Jahan and Davie, 2015; 
Krause et al., 2007). PRMTs are capable of different modes of arginine methylation classified 
into type I-III. Type I PRMTs (PRMT1, 2, 3, 4, 6 and 8; PRMT4 is also known as CARM1) 
add two methyl groups to the same amino residue of the arginine, leading to an asymmetric 
dimethylation (Gary and Clarke, 1998; Blackwell et al., 2010). Type II PRMTs (PRMT5 and 
9), in contrast, methylate two different amino groups, thereby causing symmetric 
dimethylation (Branscombe et al., 2001; Cook et al., 2006; Yang et al., 2015; Figure 11). Both 
type I and type II PRMTs do this in two steps, first monomethylating then dimethylating the 
arginine (Thandapani et al., 2013). Type III PRMTs are suggested to only be capable of 
monomethylation. There are, however, conflicting reports about PRMT7 and which group it 
belongs to. For example, Lee et al., 2005 suggested human PRMT7 to be a type II PRMT, but 
a later study could only detect (human) PRMT7-mediated monomethylation of a specific 
substrate which could be asymmetrically and symmetrically dimethylated by PRMTs 1 and 5, 
respectively (Zurita-Lopez et al., 2012). Thus, PRMT7 was classified as the only type III 
PRMT (Thandapani et al., 2013). Arginines within RGG/RG motifs are methylated by type I 
PRMTs 1, 3, 6 and 8 as well as PRMT5 (type II) (Thandapani et al., 2013). It was shown in 
cell culture that human PRMT1 methylates FMRP, a protein which depends on methylation of 
its RGG-box for regulation of RNA binding (Blackwell et al., 2010), while an in vitro study 
found a direct connection between rat PRMT1-mediated RGG methylation and RNA binding 
in human CNBP (Wei et al., 2014). 
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Figure 11: Arginine methylation by 
protein arginine methyltransferases 
(PRMTs) 
Type I, II and III PRMTs 
monomethylate one of the arginine’s 
amino groups, generating monomethyl-
arginine (MMA). In a second step, type I 
PRMTs add another methyl group to the 
same amino residue, leading to 
asymmetric dimethylation (aDMA). 
Type II PRMTs catalyze symmetric 
dimethylation (sDMA). PRMT7 (type 
III) is only capable of monomethylation 
(figure modified from Thandapani et al. 
(2013) with permission from Elsevier). 
 
 
In Drosophila, 9 homologs to the mammalian PRMTs have been identified and termed 
accordingly DART1-9 (Drosophila arginine methyltransferase) by Boulanger et al. (2004). 
They found highly conserved domains known for arginine methyltransferases and high 
homologies between DART1/PRMT1, DART4/PRMT4, DART5/PRMT5 and 
DART7/PRMT7. The remaining DARTs 2, 3, 6, 8 and 9 showed the highest similarity with 
PRMT1. Furthermore, DART1 and 4 were shown to asymmetrically dimethylate arginines 
(Boulanger et al., 2004), while DART5 and 7 are capable of symmetric dimethylation 
(Gonsalvez et al., 2008). In conjunction with the knowledge about mammalian PRMTs, 
DARTs 1 and 5 are probably the most promising candidates for regulation of RGG/RG-
mediated RNA binding in Drosophila. 
 
3.4. Ribosome biogenesis – an overview 
As explained earlier, the decreased growth and proliferation in mbm null mutant neuroblasts 
may be caused by defects in ribosome biogenesis (Hovhanyan et al., 2014). During the 
biogenesis of eukaryotic ribosomes, the small (40S) and large (60S) ribosomal subunits are 
assembled which together consist of four (in Drosophila: five) ribosomal RNAs (rRNAs) and 
79 ribosomal proteins (RPs) (Klinge et al., 2012; Pavlakis et al., 1979; Yusupova and 
Yusupov, 2014). Ribosome biogenesis starts in the fibrillar center (FC) of the nucleolus or at 
the border of the FC and the dense fibrillar component (DFC) with the transcription of the 
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ribosomal DNA (rDNA) genes by RNA polymerase I (RNA Pol. I; Boisvert et al., 2007; 
Figure 13). In Drosophila, however, the FC and DFC are substituted by the nuclear core 
which exhibits both component’s features (Knibiehler et al., 1982). Onset of rDNA 
transcription is indirectly promoted by dMyc-induced expression of RNA Pol. I cofactors 
(Grewal et al., 2005). dMyc expression, in turn, is regulated on the post-transcriptional level 
by TOR (Teleman et al., 2008; see 3.5.). Once transcribed from the rDNA genes, the pre-
rRNA consists of the 5’ and 3’ external transcribed spacer (ETS), the 18S rRNA, the internal 
transcribed spacer 1 (ITS1), the 5.8S rRNA, the internal transcribed spacer 2 (ITS2) and the 
28S rRNA (25S in lower eukaryotes like Saccharomyces cerevisiae) (Long and Dawid, 1980; 
Henras et al., 2015; Figure 12). In Drosophila, there is an additional 2S rRNA fragment which 
was found to be homologous to the 3’ end of 5.8S rRNAs of other species (Pavlakis et al., 
1979; Figure 12). Together, the 2S and 5.8S fragments form a 5.8S molecule equivalent to 
that of other species. The pre-rRNA is then processed by several steps of exo- and 
endonucleolytic cleavage, thereby cutting out the 18S, 5.8S, 2S and 28S rRNAs (see Long 
and Dawid, 1980 for a detailed description of the two possible processing pathways in 
Drosophila). The remaining 5S rRNA is transcribed separately and later joins the large 
ribosomal subunit in complex with ribosomal proteins L5 and L11 (reviewed in Klinge and 
Woolford, 2019). 
 
Figure 12: Structure of the pre-ribosomal RNA in Drosophila 
The pre-ribosomal RNA (pre-rRNA) includes the 5’ and 3’ external transcribed spacer (ETS), 18S rRNA, 
internal transcribed spacer 1 (ITS1), 5.8S rRNA, 2S rRNA, internal transcribed spacer 2 (ITS2) and the 28S 
rRNA. 
 
During rRNA processing, the intermediate rRNA fragments associate with small nucleolar 
ribonucleoproteins (snoRNPs), pre-ribosomal factors (PRFs) and ribosomal proteins (RPs). 
This happens in the DFC and the granular compartment (GC) of the nucleolus (Henras et al., 
2015; Boisvert et al., 2007; Figure 13). The RPs, e.g. RpS6, are synthesized in the cytoplasm 
and then transported into the nucleus or the nucleolus where assembly of the ribosomal 
subunits takes place (Schlosser et al., 2003; Bohnsack and Bohnsack, 2019). In the large 
RNPs that are formed in the nucleolus, the rRNAs get folded, modified and assembled with 
RPs, finally resulting in the pre-60S and pre-40S particles which are subsequently transported 
into the nucleoplasm to mature. There, additional RPs are assembled into the pre-ribosomal 
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particles. The final assembly of 40S (consisting of 18S rRNA and 33 RPs) and 60S 
(consisting of 5S, 5.8S, (2S,) 28S and 46 RPs) ribosomal subunits takes place in the 
cytoplasm, forming mature ribosomes (Bohnsack and Bohnsack, 2019; Klinge and Woolford, 
2019; Henras et al., 2015; Tschochner and Hurt, 2003; Figure 13). 
 
Figure 13: Ribosome biogenesis 
in eukaryotes 
The rDNA genes are transcribed 
in the fibrillar center (FC) or at 
the border between the FC and 
the dense fibrillar component 
(DFC). Processing of the pre-
rRNA takes place in the DFC and 
the granular component (GC) by 
interaction with pre-ribosomal 
factors (PRFs), small nucleolar 
ribonucleoproteins (snoRNPs) 
and ribosomal proteins (RPs). 
The 40S and 60S ribosomal 
subunits are assembled in the GC 
and transported to the 
nucleoplasm to mature. They 
finally join in the cytoplasm and 
form mature ribosomes (figure 
from Boisvert et al. (2007) with 
permission from Springer 
Nature). 
 
 
 
3.4.1. Ribosome heterogeneity and ribosomopathies 
Even though the process of ribosome biogenesis is highly conserved among eukaryotes, an 
increasing number of species-specific or even cell type-specific differences are found 
(reviewed in Brombin et al., 2015; Mills and Green, 2017). During assembly and maturation 
of the ribosomal subunits, numerous ribosomal biogenesis factors (RBFs) are involved in the 
structural remodeling of the pre-ribosomal particles. Functions of RBFs involve mediation of 
protein-protein interactions, the binding of RNA or enzymatic activity (Bohnsack and 
Bohnsack, 2019). RBFs are still studied extensively with new ones being discovered 
regularly. For example, Badertscher et al. (2015) found approximately 300 RBFs in human 
cells which are involved in the maturation of the small ribosomal subunit and Farley-Barnes 
et al. (2018) identified 139 potential human RBFs while screening for regulators of nucleolar 
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number. However, RBFs vary among eukaryotes and even among cell types. For example, 
Mbm was shown to be a Drosophila- as well as a neuroblast-specific RBF involved in the 
translocation of RpS6 (Hovhanyan et al., 2014) and Notchless, a maturation factor for the 
large ribosomal subunit in mice, is essential in hematopoietic stem cells but not in mature 
hematopoietic cells (Le Bouteiller et al., 2013; Brombin et al., 2015). Furthermore, stem cells 
generally exhibit higher rDNA transcription rates than their progeny, which is believed to be 
important for stem cell survival, and the down-regulation of rDNA transcription is even 
suggested to induce differentiation (Brombin et al., 2015; Hayashi et al., 2014; Zhang et al., 
2014). Moreover, ribosomes of different cell types can vary regarding the isoforms or post-
translational modifications of their RPs as well as post-transcriptional modifications of their 
rRNAs, which might be important to determine stem cell identity (Xue and Barna, 2012; 
Brombin et al., 2015; Mills and Green, 2017). 
Defects in ribosome biogenesis that lead to disease are termed ribosomopathies. 
Ribosomopathies are caused by mutations of RBFs, RPs or components of the rDNA 
transcription machinery (Bohnsack and Bohnsack, 2019). For example, mutations in eleven 
RPs of the 40S and 60S ribosomal subunit are associated with the human disease known as 
Diamond-Blackfan anemia, which is caused by inhibition of the differentiation of 
hematopoietic stem cells (Boria et al., 2010; Bohnsack and Bohnsack, 2019). In Drosophila, 
knock-out of the nucleolar and Cajal body protein Nopp140, which is considered an RBF, 
leads to intracellular ribosomopathies including the loss of RpL34 and a significant decrease 
in protein synthesis (He et al., 2015). Cell type-specific defects in ribosomopathies may be 
caused by alterations in the rRNA modification machinery or of the levels of certain RPs, 
affecting the expression of proteins required in the respective cell type. Moreover, many 
tissue-specific ribosomopathies are linked to increased levels of tumor suppressor p53, which 
causes cell cycle arrest and apoptosis (Mills and Green, 2017; Bohnsack and Bohnsack, 
2019). 
 
3.5. Ribosome biogenesis is regulated by the insulin/TOR pathway 
In Drosophila, the insulin/TOR (target of rapamycin) pathway is important for translational 
control, e.g. during starvation stress, for autophagy, endocytosis and hypoxia responses as 
well as for the control of ribosome biogenesis (reviewed in Grewal, 2009). The effects of 
insulin/TOR signaling are tissue-specific and still studied intensively. In the brain, for 
example, the insulin/TOR signaling pathway is involved in the regulation of organismal stress 
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responses whereas in the fat body it influences larval growth and adult aging (Wang et al., 
2008; Colombani et al., 2003; Giannakou and Partridge, 2007). 
In starving Drosophila larvae, insulin/TOR signaling is reduced and thereby ribosome 
synthesis is decreased, leading to reduced protein synthesis rates (Grewal et al., 2007; Hall et 
al., 2007). Secretion of insulins and subsequent binding to the insulin receptor at the cell 
surface activates a downstream signaling cascade including the kinases PI3K and Akt. The 
Akt kinase inhibits FOXO which in turn results in the activation of ribosome biogenesis 
(Oldham and Hafen, 2003; Burgering, 2008). Additionally, Akt can indirectly activate 
TORC1, a complex consisting of the TOR kinase, raptor and mLST8 (De Virgilio and 
Loewith, 2006). Both FOXO and TOR regulate Myc expression which in turn is an important 
expression regulator of many genes involved in ribosome biogenesis (Grewal et al., 2005; 
Teleman et al., 2008; Li et al., 2010; Figure 14). TOR furthermore limits cell growth in a 
nutrient-dependent manner by regulating the expression of the RNA Pol. I transcription factor 
TIF-IA. Thereby, rRNA synthesis and ribosome biogenesis is inhibited and cell as well as 
tissue growth is impeded (Grewal et al., 2007). Moreover, TIF-IA is regulated by Myc at the 
mRNA level which is another way for Myc to influence ribosome biogenesis (Grewal et al., 
2005). 
 
Figure 14: Simplified model of ribosome 
biogenesis regulation by the insulin/TOR 
pathway 
Dietary nutrients activate the insulin/TOR pathway 
which regulates expression of FOXO, Myc and 
TIF-IA, which in turn regulate ribosome 
biogenesis. On a post-translational level, 
insulin/TOR also regulates 4EPB, which inhibits 
cap-dependent mRNA translation. Thus, 
insulin/TOR regulates growth in dependence of 
nutrient availability (figure adapted from Grewal 
(2009) with permission from Elsevier). 
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One way the TOR pathway regulates Myc expression is through S6 kinase (S6K). S6K is 
phosphorylated by TOR and then promotes expression of Myc (Parisi et al., 2011). However, 
S6K is also known to phosphorylate ribosomal protein S6 (RpS6) in Drosophila (Montagne et 
al., 1999). Furthermore, Ruvinsky et al. (2005) found a connection between RpS6 
phosphorylation and the regulation of cell size in mice, while RpS6 missing its phospho-sites 
leads to an increased protein synthesis rate in mouse embryonic fibroblasts. In Arabidopsis 
thaliana, another role of phosphorylated RpS6 was suggested to be an involvement in rRNA 
synthesis (Kim et al., 2014; Son et al., 2015). In mammalian cells, a connection between TOR 
inhibition by rapamycin and RpS6 delocalization from the cytoplasm to the nucleus was 
found by Kazyken et al. (2014), even though they concluded that this effect is not caused by 
defective RpS6 phosphorylation. Given the high conservation of the TOR pathway and 
ribosome biogenesis among species, these findings may also be true in Drosophila. 
In mammalian cells, insulin/TOR signaling was additionally shown to regulate growth via 
inhibition of cap-dependent mRNA translation mediated by 4EBP (Hay and Sonenberg, 2004; 
Figure 14). Mutations of 4EPB in Drosophila have minimal to no effects on growth when 
nutrient availability is sufficient (Miron et al., 2001). Under starving conditions, however, 
4EBP mutants show a reduced life expectancy. Thus, 4EBP may be a “metabolic brake”, 
reducing energy consumption by mRNA translation when nutrients are scarce (Teleman et al., 
2005; Tettweiler et al., 2005). 
As explained previously, Myc is a transcriptional regulator of mbm, which proposes a 
potential link between insulin/TOR signaling and Mbm expression for growth control in 
neuroblasts (see 3.2.; Hovhanyan et al., 2014). It was furthermore shown that ribosome 
biogenesis and RpS6 localization are affected negatively in mbm null mutants. However, 
whether these effects are linked to the TOR pathway remains elusive so far. 
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4. Aim of the thesis 
In a previous work, it was shown that Mbm is involved in the regulation of neuroblast 
proliferation and the processing of ribosomal RNA (Hovhanyan et al., 2014). It was suggested 
that Mbm affects proliferation through a role in ribosome biosynthesis and that Mbm’s zinc-
finger motifs or its arginine/glycine rich region might be possible domains for rRNA binding. 
In a second study, flies carrying an Mbm construct with mutated zinc-fingers in the mbm null 
mutant (mbmSH1819; mbmZnF) background were generated and first experiments were 
conducted (Cornelia Engert, Master Thesis, 2015). 
The aim of this thesis was to identify a possible RNA binding domain in the arginine/glycine 
rich region of Mbm (the RGG-box) and to generate transgenic flies carrying an mbm construct 
with a deletion of the RGG-box in the mbmSH1819 background. With the help of the  
mbmSH1819; mbmZnF and mbmSH1819; mbmdRGG mutant fly lines and in cell culture experiments, 
Mbm’s molecular function in neuroblast proliferation and ribosome biogenesis should be 
further investigated. The following questions were addressed: 
- Is MbmdRGG able to rescue the survivability and reduction in neuroblast size of the 
Mbm null mutant? 
- Does Mbm rely on its RGG-box and zinc-finger motifs for its nucleolar localization? 
- Does Mbm bind ribosomal RNA in vitro and are the RGG-box and zinc-finger motifs 
important rRNA-binding domains? 
- RNA- and protein-binding functions of RGG-boxes were shown to be regulated by 
arginine methylation (see 3.3.1.). Is Mbm methylated within its RGG-box? Which 
protein arginine methyltransferases (in Drosophila: Darts) might be able to methylate 
Mbm’s RGG-box? 
- RpS6 is delocalized in mbm null mutant neuroblasts (Hovhanyan et al., 2014). Do the 
mbmdRGG and mbmZnF mutations rescue RpS6 localization? Are protein synthesis rates 
affected in mbm null, mbmdRGG and mbmZnF mutants? 
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5. Material 
5.1. Fly stocks 
Table 1: Fly lines used in this work 
Stock label Source 
w1118 T. Raabe, Würzburg, Germany 
mbmSH1819/Cyo, Ubi-GFP Oh et al., 2003 
mbmSH1819/Cyo, Ubi-GFP; pattB[mbmWT]/TM6B, Tb Hovhanyan et al., 2014 
mbmSH1819/Cyo, Ubi-GFP; pattB[mbmZnF]/TM6B, Tb Cornelia Engert (AG Raabe) 
mbmSH1819/Cyo, Ubi-GFP; pattB[mbmdRGG]/TM6B, Tb produced for this work 
mbmSH1819/Cyo, Ubi-GFP; UAS-mRFP::RpS6/TM6B, Tb Hovhanyan et al., 2014 
Mz1060-Gal4 J. Urban, Mainz, Germany 
UAS-mRFP::RpS6 Rosby et al., 2009 
 
 
5.2. Enzymes 
5.2.1. Polymerases 
Table 2: Polymerases 
Name Manufacturer 
Phusion® High-Fidelity DNA Polymerase New England Biolabs 
PowerUPTM SYBRTM Green Master Mix Applied Biosystems 
SP6 RNA Polymerase Roche 
T7 RNA Polymerase Roche 
 
5.2.2. Nucleases 
Table 3: Nucleases 
Name Manufacturer 
EcoRI-HF® New England Biolabs 
KpnI New England Biolabs 
SacI New England Biolabs 
SacII New England Biolabs 
XbaI New England Biolabs 
XhoI New England Biolabs 
 
5.2.3. Other enzymes 
Table 4: Other enzymes 
Name Manufacturer 
Arctic Phosphatase New England Biolabs 
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5.3. Reagents 
Table 5: Reagents 
Name Manufacturer 
6x DNA loading dye New England Biolabs 
Acetic acid Applichem 
Agar Kobe I (Agar agar) Carl Roth 
Albumin Fraction V (Bovine serum albumin, BSA) Applichem 
Amido black Applichem 
β-mercaptoethanol Applichem 
Bromphenol blue Applichem 
Carbenicillin Applichem 
Cellfectin Invitrogen 
Chloroform Applichem 
Color Prestained Protein Standard Broad Range 11-245 kDa New England Biolabs 
cOmpleteTM EDTA-free Protease Inhibitor Cocktail Roche 
Coomassie Brillant Blue Applichem 
CutSmart® buffer New England Biolabs 
Cycloheximide Sigma 
Diethyl pyrocarbonate (DEPC) Sigma 
Dimethyl sulfoxide (DMSO; used in cell culture) Applichem 
Dimethyl sulfoxide (DMSO; used in PCR) New England Biolabs 
Dithiothreitol (DTT) Carl Roth 
D-Lysine  
D(+)-Saccharose Molecular Biology Grade Applichem 
Dulbecco’s Phosphate Buffered Saline (PBS) PAA 
1 kb DNA Ladder New England Biolabs 
dNTPs (10 mM) New England Biolabs 
EDTA Applichem 
EGTA Applichem 
Fetal bovine serum (heat-inactivated for cell culture) Biochrom AG 
Glycerol Applichem 
Glycine Applichem 
Hygromycin B Gold InvivoGen 
Magnesium chloride hexahydrate (MgCl2) Carl Roth 
Methanol Applichem 
Midori Green Nippon Genetics 
NEBuffer 4TM New England Biolabs 
Nonfat dried milk powder Applichem 
NP-40 Applichem 
Paraformaldehyde Applichem 
Pepstatin A Roche 
10x Phosphate buffered saline (PBS) Fisher Scientific 
Penicillin PAA 
peqGOLD Universal Agarose peqLab 
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Name Manufacturer 
Phosphoric acid Carl Roth 
5x Phusion HF Buffer New England Biolabs 
Protein G Agarose Roche 
Puromycin Sigma 
RNase Inhibitor Applied Biosystems 
Rotiphorese® Gel 30 (37.5:1) Carl Roth 
Sodium chloride (NaCl) Applichem 
Sodium orthovanadate (Na3VO4) Applichem 
Sodium periodate (NaIO4) Sigma 
Streptomycin PAA 
TEMED Applichem 
Tris Ultrapure Applichem 
Triton X-100 Carl Roth 
TRIzolTM Invitrogen 
Tryptone Carl Roth 
Tween® 20 Applichem 
Vectashield Antifade Mounting Medium (H-1000) Vector Laboratories 
Yeast extract Carl Roth 
 
 
5.4. Kits 
Table 6: Kits 
Name Manufacturer 
DIG Northern Starter Kit Roche 
DIG Wash and Block Buffer Set Roche 
DNeasy Blood & Tissue Kit Qiagen 
High-Capacity cDNA Reverse Transciption Kit Applied Biosystems 
Nucleospin Gel and PCR Cleanup Macherey-Nagel 
QIAfilter Plasmid Midi Kit Qiagen 
QIAprep Spin Miniprep Kit Qiagen 
QuantiTect Reverse Transcription Kit Qiagen 
Total RNA Extraction Kit Applied Biosystems 
 
 
5.5. Cells 
Table 7: Cells 
Name Manufacturer 
Drosophila Schneider S2 cells Drosophila Genomics Resource Center (DGRC) 
E. coli DH5α Invitrogen 
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5.6. Primers 
Table 8: Primers 
Primer name Sequence (5‘-3‘) 
18S qPCR fwd TAGACCGAGAGGTCCGGGTA 
18S qPCR rev CAAAGGGCAGGGACGTAATCAA 
Akt qPCR fwd GCGCGGTTACTGTTTCACCA 
Akt qPCR rev ATGTCACGGACGATTTCACG 
Dart1-XhoI rev TATCTACTCGAGGCGCATGCGGTATGTGTTCG 
Dart5-XhoI rev ATGCCGCTCGAGCAATCGCATGTTGTAACCTGTCC 
cbp20 qPCR fwd GTCTGATTCGGTGGACTGG 
cbp20 qPCR rev CAACGTTTGCCATAACCCC 
EcoRI-Dart1 fwd CAGACTGAATTCATGGCCAGCACAGACATTCC 
KpnI-Dart5 fwd GCATGTGGTACCATGAATTACTACGTCTGTCTGCACC 
mbm fwd 33069 CGGCTCAACACGTGCGCCG 
mbm r34258 TGGACAGTTTTTGAGACC 
pAc5.1 Seq. fwd CACTACCGTTTGAGTTCTTGTGC 
pAc5.1 Seq. rev TTAGAAGGCACAGTCGAGGCTG 
Rp49 qPCR fwd GCCCAAGATCGTGAAGAAGC 
Rp49 qPCR rev CGACGCACTCTGTTGTCG 
RpL49 qPCR fwd GCCCAGCATACAGGCCCAAG 
RpL49 qPCR rev AAGCGGCGACGCACTCTGTT 
RpS6 qPCR fwd ATGAAGCAGGGTGTCTTGACC 
RpS6 qPCR rev ACGGTAGCAGGAGTGTCC 
SLIM mbm dRGG fwd short CGTAACAACTCGTGGCAACC 
SLIM mbm dRGG rev short ATTATCCAGCTCCTGTTGGG 
SLIM mbm dRGG fwd tailed CATCAGCCAAACAAGCGTAACAACTCGTGGCAACC 
SLIM mbm dRGG rev tailed CTTGTTTGGCTGATGATTATCCAGCTCCTGTTGGG 
SLIM T→C Exon 1 FS AGAAGAAGGTTAACTCCTC 
SLIM T→C Exon 1 RS GCTCCGCTTTGACAAATTGC 
SLIM T→C Exon 1 FT CCAAATCTCCTAAAAAGAAGAAGGTTAACTCCTC 
SLIM T→C Exon 1 RT TTTTAGGAGATTTGGGCTCCGCTTTGACAAATTGC 
SLIM T→C Exon 2 FS TATCGGCCGCAGCCAGTCTAC 
SLIM T→C Exon 2 RS CTCGTTTCCGCTTCTGTTTGG 
SLIM T→C Exon 2 FT GCACCAAAGCCTCCGTATCGGCCGCAGCCAGTCTAC 
SLIM T→C Exon 2 RT CGGAGGCTTTGGTGCCTCGTTTCCGCTTCTGTTTGG 
SLIM ZnF1 FS CGACAAGAAGGGCCACAC 
SLIM ZnF1 RS TCCACGGTTTTACCCTTG 
SLIM ZnF1 FT TGTGTATGGCATATGCGACAAGAAGGGCCACAC 
SLIM ZnF1 RT CATATGCCATACACATCCACGGTTTTACCCTTG 
SLIM ZnF2 FS TGCTCCGGTAGTTATCATGG 
SLIM ZnF2 RS TCTGACACTGGAAGGAGGTG 
SLIM ZnF2 FT TGATATATCGTAATTGCTCCGGTAGTTATCATGG 
SLIM ZnF2 RT ATTACGATATATCATCTGACACTGGAAGGAGGTG 
Tub qPCR fwd CGTCTGGACCACAAGTTCGA 
Tub qPCR rev CCTCCATACCCTCACCAACGT 
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5.7. Antibodies 
5.7.1. Primary antibodies 
Table 9: Primary antibodies 
Antibody Host species Application Dilution Source Cat. No. 
anti-aDMA ASYM24 rabbit WB 1:500 Merck 07-414 
anti-aPKC rabbit IF 1:25 Santa Cruz 
Biotechnology 
sc-216 
anti-dNop5 rabbit IF 1:800 G. Vorbrüggen, 
Göttingen, Germany 
 
anti-Fibrillarin 38F3 mouse IF 1:100 Santa Cruz 
Biotechnology 
sc-56676 
anti-His6 P5A11 mouse WB 1:5000 DSHB P5A11-c 
anti-Mbm EP031195 rabbit WB 1:166 Eurogentec  
anti-Mbm Syc-143 guinea pig IF 1:100 Eurogentec  
anti-Miranda 81-0 mouse IF 1:20 Fumio Matsuzaki, 
Kobe, Japan 
 
anti-myc 9E10 mouse WB, IP 1:5,000 (WB) Santa Cruz 
Biotechnology 
sc-40 
anti-sDMA SYM11 rabbit WB 1:500 Merck 07-413 
anti-Puromycin 12D10 mouse WB, IF 1:5,000 Merck MABE343 
anti-RFP rabbit IF 1:100 Abcam ab62341 
anti-RpS6 54D2 mouse IF 1:25 Cell Signaling 
Technology 
2317 
 
5.7.2. Secondary antibodies 
Table 10: Secondary antibodies 
Antibody Conjugate Host species Application Dilution Source 
anti-guinea pig Alexa488 goat IF 1:200 Dianova 
anti-guinea pig Cy3 goat IF 1:200 Dianova 
anti-mouse Cy3 goat IF 1:200 Dianova 
anti-mouse Cy5 donkey IF 1:200 Dianova 
anti-mouse Alexa488 goat IF 1:200 Dianova 
anti-mouse HRP sheep WB 1:10,000 GE Healthcare 
anti-rabbit Alexa 488 goat IF 1:200 Molecular Probes 
anti-rabbit Cy3 goat IF 1:100 Dianova 
anti-rabbit Cy5 goat IF 1:200 Dianova 
anti-rabbit HRP donkey WB 1:10,000 GE Healthcare 
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5.8. Buffers and solutions 
 
Amido black staining solution 
1 % (w/v) amido black 
10 % (v/v) acetic acid 
90 % (v/v) ethanol 
 
Apple juice agar 
8.75 g agar agar 
500 ml H2O 
→ solubilize by cooking 
12.5 g D(+)-saccharose 
125 ml apple juice 
→ solubilize under stirring at 60 °C 
→ mix both solutions 
 
Bradford reagent 
0.1 % (w/v) Coomassie Brilliant Blue 
4.5 % (v/v) ethanol 
8.5 % (v/v) phosphoric acid (H3PO4) 
 
2x D-Buffer 
20 mM Tris pH 8.0 
20 mM MgCl2 hexahydrate 
5 mM dithiothreitol (DTT) 
DEPC-H2O 
0.1 % (v/v) diethyl pyrocarbonate (DEPC) in H2O 
stirred for at least 1h, then autoclaved 
 
Dot blot destaining solution 
10 % (v/v) acetic acid 
90% (v/v) ethanol 
 
H-Buffer 
50 mM Tris pH 9.0 
20 mM EDTA pH 8.0 
300 mM NaCl 
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IP lysis buffer 
5 mM Tris pH 7.5 
150 mM NaCl 
2 mM EGTA (ethylene glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid) 
2 mM EDTA 
10 % (v/v) glycerol 
0.5 % (v/v) NP-40 
 
4x Laemmli buffer 
260 mM Tris-HCl pH 6.8 
8 % (w/v) sodium dodecyl sulfate (SDS) 
40% (v/v) glycerol 
0.01 % (w/v) bromophenol blue 
4 % (v/v) β-mercaptoethanol 
 
LBCarb 
LB medium supplemented with 100 µg/ml carbenicillin 
 
LB medium 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1% (w/v) NaCl 
 
LB Agar 
1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1% (w/v) sodium chloride 
1.4% (w/v) agar agar 
 
Native IP elution buffer 
0.2 M glycine pH 2.6 
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Native IP wash buffer 
10 mM Tris pH 7.4 
1 mM EDTA 
1 mM EGTA 
150 mM NaCl 
1% (v/v) Triton X-100 
0.2 mM Na3VO4 (sodium orthovanadate) 
 
PBT 
0.3 % (v/v) Triton X-100 in 1x PBS 
 
PLP 
2.8 % paraformaldehyde 
9.8 mM sodium periodate (NaIO4) 
73.5 mM D-lysine 
15.8 mM monosodium phosphate (NaH2PO4) 
13.6 mM disodium phosphate (Na2HPO4) 
 
RNA-binding buffer 
10 mM Tris pH 7.5 
50 mM NaCl 
1 mM MgCl2 
0.5 mM EDTA 
4 % (v/v) glycerol 
0.5 mM dithiothreitol (DTT) 
in DEPC-H2O 
 
SDS-PAGE running buffer 
25 mM Tris 
200 mM glycine 
0.1 % SDS 
 
SDS-PAGE separating gel buffer 
1.5 M Tris pH 8.8 
0.4 % SDS 
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SDS-PAGE stacking gel buffer 
0.5 M Tris pH 6.8 
0.4 % SDS 
 
50x TAE (tris-acetate-EDTA) buffer 
2 M tris 
1 M acetic acid 
50 mM EDTA 
 
Tankblot running buffer 
25mM Tris 
192 mM glycine 
20 % (v/v) methanol 
 
10x TBS (tris buffered saline) 
100 mM tris pH 7.5 
1.5 M NaCl 
 
TBS-T 
1x TBS 
0.1 % Tween® 20 
 
 
5.9. Machines, equipment and software 
5.9.1. Machines 
Table 11: Machines 
Name Manufacturer 
7-2020 (vortexer) neoLab 
accu-jet Pro (pipette) Brand 
Analytic A200S (balance) Sartorius 
Arpege 40 (liquid nitrogen tank) Air Liquide 
BioPhotometer Eppendorf 
Centrifuge 5415 D Eppendorf 
Centrifuge 5415 R Eppendorf 
Centrifuge 5417 R Eppendorf 
ChemoCam Imager Intas Science Imaging 
Criterion Blotter (Bio-Rad) 
Easypet (pipette) Eppendorf 
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Name Manufacturer 
E-BOX VX2 Gel Documentation System peqLab 
Electronicrührer Monotherm Variomag 
EPS600 (PSU) Pharmacia Biotech 
FLUOVIEW 1000 IX81 Olympus 
Gel iX Imager Intas Science Imaging 
GNA 100 (electrophoresis chamber) Pharmacia Biotech 
Heraeus Multifuge X1R Thermo Scientific 
INB 400 (incubator) Memmert 
innova 4330 Refrigerated Incubator Shaker New Brunswick Scientific 
IPP 110 (incubator) Memmert 
KL 200 LED (binoculars) Zeiss 
LaminAir HB 2448 (sterile bench) Heraeus Instruments 
LD79 (rotator) Labinco BV 
Mastercycler® ep Gradient S Eppendorf 
Mastercycler® Gradient Eppendorf 
Mini-PROTEAN Tetra System Bio-Rad 
Mixing Block MB-102 BIOER 
Multigel (SDS-PAGE chamber) Biometra 
Mz16F (fluorescence binoculars) Leica 
NanoDrop 2000c UV-Vis Spectrophotometer Thermo Scientific 
Orbital Shaker-Incubator ES-20 Grant-bio 
Pipetman P20 Gilson 
Pipetman P200 Gilson 
Pipetus Hirschmann Laborgeräte 
Platefuge Benchmark Scientific 
PowerPac 200 Bio-Rad 
Reference pipettes 10, 100 & 1000 µl Eppendorf 
RS-RT05 (rollator) Phoenix Instruments 
Seven Easy (pH-meter) Mettler Toledo 
Sonorex (sonicator) Bandelin 
SPO 61 (balance) Scaltec 
StepOne Plus Real Time PCR System Applied Biosystems 
Sub-Cell GT (electrophoresis chamber) Bio-Rad 
TCS SPE Leica 
Thermomixer comfort Eppendorf 
Typ 12801 (heating plate) Medax 
Unimax 2010 (shaker) Heidolf 
UVC500 UV Crosslinker Hoefer 
Vortex-Genie 2 Scientific Industries 
WS-5 (shaker) Edmund Bühler 
WT-17 (nutator) Biometra 
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5.9.2. Equipment 
Table 12: Equipment 
Name Manufacturer 
6 cm petri dishes greiner bio-one 
6-Well plates Sarstedt 
Cell culture flasks 25 ml Sarsted 
Cell culture flasks 75 ml Sarsted 
Cover slips Marienfeld 
Cryovials nunc 
Hybond® P Western blotting membrane, PVDF Amersham 
Neubauer improved cell counting chamber Hausser Scientific 
Protran BA 85 (0.45 µm nitrocellulose membrane) GE Healthcare Life Sciences 
Object slides Marienfeld 
X-ray film Typon Röntgenfilm GMBH 
 
 
5.9.3. Software 
Table 13: Software 
Name Manufacturer/Source 
Corel Draw X5 Corel 
Corel Draw 2018 Corel 
Fiji (ImageJ) https://fiji.sc/; Schindelin et al., 2012 
GENtle v.1.9.4 gentle.magnusmanske.de 
MUSCLE https://www.ebi.ac.uk/Tools/msa/muscle/; 
Chojnacki et al., 2017 
NEBioCalculatorTM https://nebiocalculator.neb.com/#!/ligation 
Office 2010 Microsoft 
Office 365 Microsoft 
Origin 2018b 64Bit OriginLabs Corporation 
Primer-BLAST https://www.ncbi.nlm.nih.gov/tools/primer-blast/ 
R v.3.0.1 www.r-project.org 
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6. Methods 
6.1. General molecular biology methods 
6.1.1. Extraction of genomic DNA (gDNA) from Drosophila S2R+ cells 
Stably or transiently transfected S2R+ cell lines were grown to approximately 1 x 107 
cells/ml. 2 ml of cell suspension were centrifuged at 1,200 x g for 5 min, the supernatant was 
discarded and the cell pellet was resuspended in 5 ml PBS (Dulbecco’s Phosphate Buffered 
Saline, PAA). Following centrifugation at 1,200 x g for 5 min, the pellet was resuspended in 
200 µl PBS. gDNA was extracted using the DNeasy Blood & Tissue Kit (Qiagen) according 
to the kit’s “Animal Blood (Spin-Column Protocol)” starting at paragraph 1c with the addition 
of 20 µl proteinase K. 
 
6.1.2. Polymerase chain reaction (PCR) 
To amplify desired stretches of DNA, standard PCR was performed in an Eppendorf 
Mastercycler® ep Gradient S using Phusion® High Fidelity DNA Polymerase (New England 
Biolabs (NEB)). Primers were designed with GENtle v.1.9.4. (gentle.magnusmanske.de) and 
ordered from Thermo Scientific. The annealing temperature of the specific primer pair was 
determined using NEB’s Tm calculator (https://tmcalculator.neb.com). See Table 14 and 
Table 15 for the composition and the cycle of a standard PCR, respectively. 
Table 14: standard PCR components 
Reagent Volume (µl) Final concentration 
5x Phusion HF Buffer (NEB) 10 1x 
10 mM dNTPs 1 0.2 mM 
10 µM fwd primer 2.5 0.5 µM 
10 µM rev primer 2.5 0.5 µM 
DNA template variable variable 
optional: DMSO (NEB) 2.5 5% 
Phusion High Fidelity Polymerase (NEB) 0.5 1 U 
H2O ad 50 µl  
 
Table 15: standard PCR cycle 
Temperature Time Number of cycles 
98 °C 30 s 1 
98 °C 10 s  
variable 20 s 25-35 
72 °C 30s / kb  
72 °C 10 min 1 
4 °C ∞  
Methods 
39 
 
6.1.3. Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments according their size. 1% 
(w/v) agarose gels in 1x TAE buffer were prepared and 2.5 µl of Midori Green (Nippon 
Genetics) were added. The DNA samples were mixed in a 1:6 ratio with 6x DNA loading dye 
and loaded onto the gel. 5 µl 1 kb DNA Ladder (NEB) were used for size reference. The 
electrophoresis was carried out by applying 80 to 120 V for 60 to 90 min. A Gel iX Imager 
(Intas Science Imaging) or an E-BOX VX2 Gel Documentation System (peqLab) was used to 
visualize DNA fragments using UV light. 
 
6.1.4. Restriction digestion 
To prepare DNA fragments and plasmids for cloning or to screen clones for successful 
insertion, a restriction digestion was performed (Table 16). Unless mentioned otherwise, 
digestions were carried out at 37 °C for 1 h. 
Table 16: Standard restriction digestion 
Reagent Volume (µl) 
10x restriction buffer (variable) 2.5 
plasmid DNA (up to 1 µg) variable 
Restriction enzyme I 0.5 
(Restriction enzyme II 0.5) 
H2O ad 25 µl 
 
 
6.1.5. Cloning 
Cloning was performed to insert a DNA fragment amplified by PCR into vector DNA or to 
transfer DNA fragments between plasmids. Complementary overhangs on both the recipient 
plasmid as well as the insert DNA were generated by restriction digestion (see 6.1.4.). The 
linearized vector was dephosphorylated using Antarctic Phosphatase (NEB) to prevent 
recircularization (Table 17). Dephosphorylation was performed for 1 h at 37 °C. The reaction 
was stopped by incubation at 80 °C for 2 min. 
Table 17: Composition of a dephosphorylation reaction 
Reagent Volume (µl) 
linearized vector variable (2 µg of DNA) 
10x Antarctic Phosphatase Buffer (NEB) 3 
Antarctic Phosphatase (NEB) 2 
H2O ad 30 µl 
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The digested insert and vector were run through a 1% agarose gel (see 6.1.3.). The desired 
DNA fragments were extracted from the agarose gel slices using the Nucleospin Gel and PCR 
Cleanup kit (Macherey-Nagel) according to the kit’s protocol. The DNA was eluted with 20 
µl H2O and the DNA concentration was measured using a BioPhotometer (Eppendorf). 
The ligation was carried out with an insert:vector ratio of 5:1. The insert DNA mass to be 
used for 100 ng of vector DNA was calculated with the ligation module of  
NEBioCalculatorTM. See Table 18 for the composition of a standard ligation reaction. Before 
the ligase was added, the ligation reaction was incubated at 45 °C for 5 min and briefly cooled 
down on ice. After the addition of the ligase, the reaction was carried out at 16 °C for 2 h. 
Following a further incubation step at RT for 10 min, 5 µl of the ligation reaction were used 
for transformation into E. coli DH5α (Invitrogen) (see 6.1.6.) 
Table 18: Composition of a standard ligation reaction 
Reagent Volume (µl) 
10x T4 DNA Ligase Buffer (NEB) 2 
linearized vector variable (100 ng of vector DNA) 
insert DNA variable (5:1 insert:vector ratio) 
T4 DNA Ligase (NEB) 1 
H2O ad 20 µl 
 
 
6.1.6. Transformation 
The amplification of plasmid DNA was achieved by transformation into E. coli DH5α cells 
(Invitrogen). 50 µl E. coli DH5α suspension stored at -80 °C was thawed on ice for 30 min. 
Plasmid DNA (variable amount) was added, the probe was mixed by flipping and incubated 
on ice for 20 min. The bacteria were heat-shocked at 42 °C for 60 s, briefly put back on ice 
and 300 µl LB medium containing 100 µg/ml carbenicillin (Applichem; henceforth called 
LBCarb) were added (note: all vectors used in this work carry a resistance gene for ampicillin, 
for which carbenicillin is a more stable analog). The sample was incubated in a thermoshaker 
at 37 °C for 1 h under shaking at 300 rpm before it was plated onto an LB-agar plate 
containing 100 µg/ml carbenicillin. Incubation occured at 37 °C overnight. 
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6.1.7. Miniprep 
Plasmid DNA was extracted from liquid E. coli culture using the QIAprep Spin Miniprep Kit 
(Qiagen). A clone of previously transformed E. coli was picked carefully with a pipette tip, 
added to a test tube with 2 ml LBCarb and incubated at 37 °C and 180 rpm for at least 5 h. The 
bacteria suspension was pelleted by centrifugation at 16,000 x g for 1 min. The supernatant 
was discarded and the plasmid DNA was extracted from the cell pellet according to the kit’s 
„QIAprep spin“ protocol. The DNA was eluted using 30 µl of H2O. 
 
6.1.8. Sequencing 
Sequencing of plasmid DNA as well as purified PCR products was carried out by Eurofins 
Genomics (85560 Ebersberg, Germany) using their „TubeSeq Service“. The DNA 
concentration of the sample was measured with a BioPhotometer (Eppendorf) or with a 
NanoDrop 2000c UV-Vis Spectrophotometer (Thermo Scientific). Sample preparation was 
done according to Eurofins’ “TubeSeq Service Sample Submission Guide”. The results were 
analyzed using GENtle v.1.9.4. 
 
6.1.9. Midiprep 
Plasmid DNA of a clone carrying the desired construct was amplified via midiprep using the 
QIAfilter Plasmid Midi Kit (Qiagen). 50 ml of LBCarb were inoculated with the desired E. coli 
clone. Following overnight incubation at 37 °C and 180 rpm, the bacteria suspension was 
centrifuged for 15 min at 5,000 x g. The supernatant was discarded and the pellet was 
resuspended in 4 ml Buffer P1 (Qiagen). The midiprep was carried out according to the kit’s 
protocol except for steps 11 and 12, when the centrifugation steps were performed at 5,000 x 
g and 4 °C for 60 min and 30 min, respectively. The plasmid DNA was redissolved in H2O by 
vigorous shaking on a vortexer for at least 30 min. 
 
6.1.10. RNA extraction 
Total RNA was extracted from Drosophila larval brains using TRIzolTM (Invitrogen). 15 
brains were dissected and transferred into a 1.5 ml reaction tube on ice containing 10 µl 1x 
PBS (diluted from 10x PBS (Fisher Scientific) with DEPC-H2O). 1 ml of TRIzol was added, 
the sample was sonicated 3x 30 s and put on ice for 30 s between each sonication. 200 µl 
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chloroform were added, the sample was mixed, incubated for 3 min and centrifuged at 12,000 
x g for 15 min. The aqueous phase was carefully pipetted into a new 1.5 ml reaction tube. The 
RNA extraction was subsequently performed according to the TRIzolTM reagent’s protocol. 
20 µl DEPC-H2O were used for the resuspension of the RNA. The yield was determined using 
a NanoDrop 2000c UV-Vis Spectrophotometer (Thermo Scientific). 
 
6.1.11. Reverse transcription 
RNA was reverse transcribed into cDNA using either the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems) or the QuantiTect Reverse Transcription Kit (Qiagen) 
following the respective protocol. 
 
6.1.12. Quantitative real-time PCR (qPCR) 
qPCR was performed to investigate the expression levels of certain genes of interest in 
Drosophila larval brains. Total RNA was extracted and reverse transcribed into cDNA as 
described in sections 6.1.10. and 6.1.11. Primers for qPCR were designed using GENtle 
v.1.9.4. and checked for unspecific binding sites, matching melting temperatures (58 ±1 °C) 
as well as the probability of primer dimer formation using Primer-BLAST. qPCRs were 
carried out in a StepOne Plus Real Time PCR System (Applied Biosystems) using 
PowerUPTM SYBRTM Green Master Mix (Applied Biosystems) according to the kit’s protocol 
with an annealing temperature of 58 °C. The optimal concentrations of both the forward and 
reverse primers were determined running a qPCR with 1 ng of template cDNA and all 
possible combinations of 100 nM, 300 nM and 600 nM of both primers. The combination for 
which the qPCR yielded the earliest start of the exponential phase as well as a melting curve 
fitting the expected product was used for further qPCR runs. The primer efficiency was 
determined by a qPCR run with a 7-fold 1:5 serial dilution starting with 10 ng and all samples 
were run in dublicates. The Ct values were plotted against the log-transformed dilutions of 
template cDNA and the slope of the regression line was used to calculate the primer 
efficiency: 
𝑒𝑓𝑓𝑖𝑒𝑛𝑐𝑦 = (5
−1
𝑠𝑙𝑜𝑝𝑒 𝑜𝑓 𝑟𝑒𝑔𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑙𝑖𝑛𝑒 − 1) 
Additionally, the R2 value of the regression line was verified to be over 0.98, so that the 
precision of the regression line could be trusted. All further experiments were run in 
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triplicates with 1 ng of template cDNA and the previously determined optimal primer 
concentration. The fold change in expression of a gene of interest in two different genotypes 
was calculated in comparison to a housekeeping gene using the ddCt method (Livak and 
Schmittgen, 2001). Statistical analysis was done by a Mann-Whitney U test in Origin (in 
accordance with Goni et al, 2009). 
 
6.2. General biochemistry methods 
6.2.1. Immunoprecipitation (IP) 
Proteins expressed in Drosophila S2R+ cells were isolated by immunoprecipitation (IP). To 
this end, 4 ml of cell suspension with a density of 5 to 10 x 106 cells/ml were centrifuged at 
1,200 x g and 4 °C for 5 min, the supernatant was discarded. The pellet was washed by 
resuspension in 10 ml Dulbecco’s PBS (ice-cold; PAA) and centrifugation at 1,200 x g for 5 
min. The pellet was washed once more with 2 ml cold PBS and transferred into a 2 ml 
reaction tube. Following another centrifugation at 1,200 x g and 4 °C for 5 min, the 
supernatant was discarded and the pellet was resuspended in 100 µl IP lysis buffer 
supplemented with 1x cOmpleteTM EDTA-free Protease Inhibitor Cocktail (Roche) and 0.7 
µg/ml pepstatin A (Roche). Following incubation at 4 °C on a rotator for 40 min, the lysate 
was centrifuged at 1,200 x g and 4 °C for 5 min. The supernatant was transferred into a pre-
cooled 1.5 ml reaction tube. 50 µl protein G agarose beads (Roche) were added and the 
sample was incubated on a rotator at 4 °C for 1 h. The beads were pelleted at 12,000 x g and  
4 °C for 1 min and the supernatant was transferred into a new pre-cooled 1.5 ml reaction tube. 
Following the addition of the antibody (amount depending on the antibody used), the sample 
was incubated overnight on a rotator at 4 °C. 80 µl protein G agarose beads were added and 
the sample was put on a rotator at 4 °C for 3 h. The beads were then washed 3x with 1 ml IP 
lysis buffer (supplemented with the previously mentioned protease inhibitors) by 
centrifugation at 12,000 x g and 4 °C for 1 min and discarding the supernatant. Elution of the 
proteins was performed by adding 80 µl 2x Laemmli buffer and heating to 95 °C for 5 min. 
The protein G agarose beads were pelleted by centrifugation at 12,000 x g for 1 min, before 
the samples were loaded onto an SDS-PAGE gel (see 6.2.4.) 
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6.2.2. Native immunoprecipitation 
Native immunoprecipitation was performed to isolate proteins in their native, non-denatured 
state to use them for down-stream experiments. Native IP was done according to standard IP 
with the following exceptions: 150 µl IP lysis buffer (with protease inhibitors) were used for 
lysis of the cells and the cell suspension was sonified for 5x 30 s in cold water and put on ice 
for 30 s between each sonification step before incubation at 4 °C for 40 min. 100 µl and 200 
µl protein G agarose beads (Roche) were used for preclearing of the lysate and the 
immunoprecipitation, respectively. The washing steps were performed with 500 µl native IP 
washing buffer supplemented with 1x cOmpleteTM EDTA-free Protease Inhibitor Cocktail 
(Roche) and 0.7 µg/ml pepstatin A (Roche). Elution of the proteins was carried out by adding 
200 µl native IP elution buffer, incubation on a rotator at 4 °C for 20 min and pelleting of the 
beads at 12,000 x g and 4 °C for 1 min. The supernatant was transferred into a pre-cooled 1.5 
ml reaction tube and mixed with 200 µl 1 M Tris-HCl pH 8.0. The IP product was aliquoted, 
immediately shock-frozen in liquid nitrogen and stored at -80 °C. 
 
6.2.3. Measurement of protein concentrations 
6.2.3.1. Bradford Assay 
The protein concentrations in cell or tissue lysates without Laemmli buffer were be measured 
by Bradford assay (Bradford, 1976). 120 µl of the lysate were mixed with 950 µl Bradford 
solution and the OD600 was measured using a BioPhotometer (Eppendorf). Using known BSA 
concentrations, a standard curve was determined and used to calculate the protein 
concentrations of the samples. 
6.2.3.2. Dot blot 
To estimate the concentration of a protein sample mixed with Laemmli buffer, a dot blot was 
performed. First, a serial dilution of BSA with concentrations between 0.025 µg/µl and 1 
µg/µl was prepared. 8 µl of each BSA dilution and 8 µl of each sample were mixed with 8 µl 
methanol (MeOH). Of each sample, 3 x 3 µl were pipetted onto a PVDF membrane 
(Amersham) and allowed to air-dry. The membrane was then stained for 3 min in amido black 
staining solution and washed 3 x 10 min in destaining solution. The protein concentration of 
the samples was subsequently estimated by comparison of their staining intensity with the 
intensity of the different BSA dilutions. 
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6.2.4. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples prepared for western or northwestern blot were subjected to SDS-PAGE to 
separate the proteins according to their molecular weight (after Laemmli, 1970). The gels 
were prepared with a 4 % stacking and a 9 % separating gel (Table 19). For subsequent 
northwestern blots, 5 % glycerol were added to the separating gel and only DEPC-H2O was 
used for all buffers. The samples (mixed with Laemmli buffer) as well as 5 µl of Color 
Prestained Protein Standard Broad Range 11-245 kDa (NEB) were incubated at 95 °C for 5 
min and briefly cooled down on ice before equal amounts of protein were loaded on the gel. 
The gel was run at 80 V until the probes had entered the separating gel and then at 150 to 200 
V until the colored running front was nearly running out of the gel. 
Table 19: Composition of SDS-PAGE gels 
4 % stacking gel 9 % separating gel 
Reagent Volume Reagent Volume 
Stacking gel buffer 2.5 ml Separating gel buffer 2.5 ml 
Rotiphorese® Gel 30 (37.5:1) 1.3 ml Rotiphorese® Gel 30 (37.5:1) 3.0 ml 
H2O 6.2 ml H2O 4.5 ml 
TEMED 70 µl TEMED 70 µl 
10 % ammonium persulfate 14 µl 10 % ammonium persulfate 7 µl 
 
 
6.2.5. Western blot (WB) 
Using a CriterionTM Blotter (Bio-Rad) tankblot system according to its manual, western blots 
were performed to transfer proteins from an SDS-PAGE gel to a nitrocellulose or a PVDF 
membrane for immunodetection of the protein(s) of interest. Following transfer at 80 V for 30 
min, the membrane was blocked with 5 % (w/v) milk powder in TBS-T or 3 % (w/v) BSA in 
TBS-T for 1h at RT. Primary antibody incubation was done overnight in blocking solution in 
a 50 ml reaction tube on a rollator at 4 °C. Following washing with TBS-T 3x 15 minutes, 
incubation with the secondary, HRP-linked antibody diluted in TBS-T occurred for 1 h at RT. 
After additional washing steps with TBS-T for 3x 8 min at RT, detection of the blot was 
performed using ECLTM Prime Western Blotting System (GE Healthcare) and a ChemoCam 
Imager (Intas Science Imaging) or an x-ray film (Typon Röntgenfilm GMBH). 
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6.2.6. Northwestern blot 
Northwestern blots were performed to visualize RNA-protein hybrids separated by an SDS-
PAGE. Transfer of the proteins to a PVDF membrane was carried out using a CriterionTM 
Blotter (Bio-Rad) tankblot system according to its manual. The tankblot running buffer was 
prepared with DEPC-H2O. Following blotting, the membrane was baked on a heating plate at 
80 °C for 1 h. Blocking and detection were performed using the DIG Wash and Block Buffer 
Set (Roche) according to its manual, however without the hybridization steps. Visualization 
was done with a ChemoCam Imager (Intas Science Imaging) or an x-ray film (Typon 
Röntgenfilm GMBH). 
 
6.3. Maintaining of fly lines 
Flies were kept in glass vials with a height of 9 cm and a diameter of 3 cm or in plastic vials 
with a height of 4.5 cm and a diameter of 9.5 cm. The nutrition medium consisted of 0.8% 
agar, 2.2% sugar beet molasses, 8.0% malt extract, 1.8% yeast, 1.0% soy flour, 8.0% corn 
flour and 0.3% hydrobenzoic acid. Fly vials were maintained in a climate chamber at 25 °C 
and a relative humidity of ~60% with a 12:12h light:dark (LD) cycle. 
 
6.4. Generation of an mbmdRGG mutant fly line 
In previous works, fly lines carrying either a wild-type or a zinc-finger mutant genomic 
construct of mbm on the third chromosome and an mbm null mutation on the second 
chromosome have been generated (Hovhanyan et al., 2014; Cornelia Engert, Master Thesis, 
2015). To this end, mbm was amplified from genomic DNA (gDNA) via PCR and cloned into 
the pUASTattB vector (Bischof et al., 2007). This pUASTattB-mbmWT construct was 
modified via mutagenesis PCR to mutate Mbm’s two zinc-finger domains, thereby generating 
pUASTattB-mbmZnF. Both constructs were injected into Drosophila melanogaster embryos by 
BestGene Inc (Chino Hills, CA 91709, U.S.A.). The pUASTattB transformation vector 
enables transgenesis into the genome at an attP site mediated by PhiC31 integrase. In the flies 
used for injection (BDSC #9750), this attP site is located at chromosomal position 65B2 on 
the 3rd chromosome (Anna Hovhanyan, PhD Thesis, 2014; Cornelia Engert, Master Thesis, 
2015; BestGene Inc.). The injected fly lines were crossed into an mbm null mutant 
background (Cornelia Engert, Master Thesis, 2015). 
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In this work, a new fly line was generated which carries a genomic, RGG-box deleted 
construct of mbm. To this end, the existing pUASTattB-mbmWT constuct was mutated via 
SLIM-PCR (Chiu et al., 2004) to delete the RGG-box and sent to BestGene Inc. for injection. 
Several independent transgenic fly lines were obtained and crossed into the mbm null mutant 
background. 
 
6.4.1. Site-directed, ligase-independent mutagenesis (SLIM) PCR 
To delete Mbm’s RGG-box from pUASTattB-mbmWT, SLIM-PCR (Chiu et al., 2004) was 
performed. The basic principle of a deletion via SLIM-PCR relies on the use of two primer 
pairs in a single PCR reaction. One primer pair flanks the sequence to be deleted, the other 
pair is identical to the first pair on the 3‘ end, but with 15 nucleotide long complementary 
overhangs on the 5‘ end. This PCR reaction linearizes the pUASTattB-mbmWT plasmid and 
deletes the RGG-box, leading to four different products either with no overhang, overhangs 
on both ends or with overhangs only on the 5‘ or on the 3‘ prime end (of the coding strand). 
The denaturation and re-hybridization of the mixture of PCR products leads to only two 
hybrids that feature complementary overhangs on both ends, thereby enabling 
recircularization and transformation into E. coli. The benefit of this method is that only the 
correct products are able to recircularize, leading to very few viable E. coli clones under 
antibiotic selection which mostly contain the correct plasmid. The following protocol was 
adapted from the original publication by Chiu et al. (2004). 
SLIM-PCR was performed using the non-tailed primers flanking mbm’s RGG-box (primers 
“SLIM mbm dRGG fwd short” and “rev short”) and the tailed primers (“SLIM mbm dRGG 
fwd tailed” and “rev tailed”, Table 8) in a single reaction. Thereby, pUASTattB-mbmWT was 
linearized and amplified without the RGG-box, resulting in pUASTattB-mbmdRGG (see Table 
20 and Table 21 for the SLIM PCR protocol). The annealing temperature was determined 
using NEB’s Tm calculator (https://tmcalculator.neb.com), only considering the non-tailed 
primers. 
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Table 20: SLIM-PCR components 
Reagent Volume (µl) Final concentration 
5x Phusion HF Buffer (NEB) 10 1x 
10 mM dNTPs 1 0.2 mM 
10 µM Primer Mix 1 0.2 µM 
DNA template (200 pg/µl) 1 1 ng 
DMSO (NEB) 2.5 5% 
Phusion High Fidelity Polymerase (NEB) 0.5 1 U 
H2O ad 50 µl  
 
Table 21: SLIM-PCR cycle 
Temperature Time Number of cycles 
98 °C 1 min 1 
98 °C 10 s  
61 °C 20 s 30 
72 °C 6 min  
72 °C 10 min 1 
4 °C ∞  
 
To eliminate the template DNA from the mixture, the PCR product was digested with DpnI.  
5 µl 2x D-Buffer, 0.5 µl DpnI (NEB) and 4.5 µl H2O were added to the PCR product to a final 
volume of 60 µl. The mixture was incubated at 37 °C for 2 h. 25 µl of the digested sample 
were mixed with 25 µl H-Buffer, denatured at 99 °C for 3 min and hybridized in two cycles of 
65 °C for 5 min and 30 °C for 15 min. 5 µl of the hybridization product were used for 
transformation into E. coli DH5α (Invitrogen) (see 6.1.6.). Following miniprep (see 6.1.7.), 
the success of the SLIM was verified by sequencing with the primers „mbm fwd 33069“ 
(Table 8) as described earlier (see 6.1.8.). A correct clone was amplified by transformation 
into E. coli and isolated by midiprep (see 6.1.9.). 
 
6.4.2. Injection into fly embryos by BestGene Inc. 
The midiprep product of the desired construct pUASTattB-mbmdRGG was sent to BestGene 
Inc. (Chino Hills, CA, U.S.A.) for injection into Drosophila melanogaster embryos and 
PhiC31 mediated integration into the genome at the attP site at chromosomal position 65B2 
on the 3rd chromosome (BDSC stock #9750). 
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6.4.3. Crossing into mbm null mutant background 
The P[mbmdRGG] fly lines received from BestGene Inc. were crossed over balancer 
chromosomes TM6B, Tb and then into the mbm null mutant background called mbmSH1819. 
The final genotype was  +; 
𝑃[𝑚𝑏𝑚𝑆𝐻1819]
𝐶𝑦𝑜,   𝑈𝑏𝑖−𝐺𝐹𝑃
;  
𝑃[𝑚𝑏𝑚𝑑𝑅𝐺𝐺]
𝑇𝑀6𝐵,   𝑇𝑏
. These crossings were carried out by 
Prof. Dr. Thomas Raabe. 
Homozygous larvae with the genotype +; P[mbmSH1819]; P[mbmdRGG] were used for 
experiments and are henceforth called mbmSH1819; mbmdRGG. 
 
6.5. Survival Assay 
To investigate the viability of the mbm null mutant (mbmSH1819), dRGG mutant (mbmSH1819; 
mbmdRGG) and zinc-finger mutant (mbmSH1819; mbmZnF) fly lines as well as the genomic rescue 
line (mbmSH1819; mbmWT), homozygous larvae were selected and their development monitored 
over the course of at least 14 days. 
The fly stocks were transferred to apple juice agar plates for controlled egg deposition. To 
prepare these plates, 8.75 g agar agar were solubilized in 500 ml H2O by boiling in a 
microwave oven. Seperately, 12.5 g D(+)-Saccharose were solubilized in 125 ml apple juice 
by heating to 60 °C and stirring with a magnetic stirrer. Both solutions were mixed and then 
poured into petri dishes with a diameter of 6 cm. Finally, a solution of approximately 500 mg 
baker’s yeast in 5 ml H2O was applied to the surface of the apple juice agar with a paintbrush 
and allowed to air-dry. 
The flies were transferred onto the apple juice agar plates and kept in a climate chamber at 25 
°C for 24 h. The flies were discarded and larvae homozygous for mbmSH1819, mbmSH1819; 
mbmdRGG, mbmSH1819; mbmZnF or mbmSH1819; mbmWT were selected and transferred to petri 
dishes containing fly nutrition medium (see 6.3). The next 14 days, the plates were kept at 25 
°C and pupae as well as fully eclosed adult flies were counted. 
w1118 was used as a wild-type (negative) control and the mbm null mutant mbmSH1819 as a 
positive control. The rescue line mbmSH1819; mbmWT was included to see whether the genomic 
mbm construct inserted into the 3rd chromosome at position 65B2 is generally able to revert 
the mbmSH1819 phenotype. Percentages of larvae that pupated and that finally reached 
adulthood, respectively, were determined in seven independent experiments. Statistical 
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analysis was done with Origin 2018b by usage of a Mann-Whitney-U test. Alpha error 
accumulation was adjusted by Bonferroni correction. 
 
6.6. Immunostainings of larval brains 
Immunostainings were performed to investigate the localization of specific proteins in larval 
brain neuroblasts of the different mbm mutant fly lines. To this end, L3 larvae were selected, 
brains were dissected in 1x PBS (Fisher Scientific) and transferred into fixation solution 
(PLP; see 5.8.). Following fixation for 25 min on ice, the brains were washed in 0.3 % Triton 
X-100 in PBS (PBT) at RT on a nutator for 10 min or until the brains of all other fly lines 
were ready to continue. All following steps were carried out on a nutator. Blocking was 
performed in 3% normal goat serum (NGS) in PBT at RT for 2h. The brains were incubated 
overnight in a solution of primary antibodies (Table 9) in 3 % NGS in PBT at 4 °C. After 
washing three times for 1 h in PBT at RT, the brains were subjected to a dilution of secondary 
antibodies (Table 10) in PBT in the dark, either for 3 h at RT or overnight at 4 °C. The final 
washing step was carried out overnight in PBT in the dark at 4 °C. The brains were then 
embedded on an object slide in a drop of Vectashield (Vector Laboratories) and covered with 
a cover slide which was fixated with nail polish. 
Confocal laser-scanning microscopy (CLSM) was performed with an Olympus FLUOVIEW 
1000 IX81 or a Leica TCS SPE using a 40x oil immersion objective with 3x digital zoom and 
a step size of 0.7 µm. The Z-stack generated by the microscope’s software was opened in and 
modified with Fiji (ImageJ) (Schindelin et al., 2012).  
 
6.6.1. Neuroblast (NB) cell size measurements 
Neuroblast cell sizes were measured using CLSM image stacks of immunostained L3 larval 
brains and Fiji (Schindelin et al., 2012). The cell membranes of the neuroblasts could be 
determined by antibody-staining against NB specific markers aPKC and/or Miranda. Each 
neuroblast was measured using Fiji’s free hand tool in the focal plane in which its area was 
the biggest. The NB areas in µm² of each genotype were averaged and then used for statistical 
analysis. Normal distribution was confirmed by a Kolmogorov-Smirnov test and significance 
was tested by a Student’s t-test using Origin 2018b (OriginLabs). Alpha error accumulation 
was corrected by Bonferroni correction. 
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6.7. Generation of stable mbm overexpression Drosophila S2R+ cell lines 
Several experiments required the expression of the mbm constructs mbmWT, mbmdRGG, mbmZnF 
as well as a double mutant mbmdRGG, ZnF in Drosophila Schneider S2R+ cells (Drosophila 
Genomics Resource Center, DGRC). In a previous work, an S2R+ cell line carrying the 
overexpression construct pAc5.1-myc-mbmWT was generated (Roland Jeblick, Diploma 
Thesis, 2006). In the present work, the pAc5.1-myc-mbmWT plasmid was newly generated 
from this cell line and subjected to SLIM to generate the dRGG, the ZnF as well as the 
dRGG, ZnF double mutant. 
 
6.7.1. Cloning of pAc5.1-myc-mbmWT 
Total gDNA of the stable cell line carrying pAc5.1-myc-mbmWT was extracted as described 
previously (see 6.1.1.). To amplify mbmWT including the flanking restrictions sites EcoRI and 
XhoI, standard PCR was performed (see 6.1.2.) using 5 µl gDNA. pAc5.1 sequencing primers 
were used, annealing was performed at 68 °C and the PCR was run for 30 cycles. The success 
of the PCR was verified via agarose gel electrophoresis (see 5.1.3). For further amplification, 
1 µl of PCR product was used in a second PCR otherwise carried out like the first one. This 
second PCR product was purified using the Nucleospin Gel and PCR Cleanup kit (Macherey-
Nagel) according to the kit’s protocol. The DNA was eluted with 20 µl H2O. To clone mbmWT 
into the pAc5.1-myc vector, 19 µl of purified PCR product and 2 µg of pAc5.1-myc vector 
were digested with EcoRI-HF® and XhoI (NEB) using NEB’s CutSmart® buffer. Both 
reactions were upscaled to a total volume of 50 µl and otherwise carried out as described 
previously (see 6.1.4 through 6.1.6.). Miniprep (section 6.1.7.), control restriction digestion 
(6.1.4.), sequencing (6.1.8.) and midiprep (6.1.9.) were performed as described previously. 
For sequencing, pAc5.1 sequencing primers were used and the results were analyzed using 
GENtle v.1.9.4. 
 
6.7.2. Mutagenesis of the RGG-box and/or the zinc-finger domains in pAc5.1-myc-mbm 
via SLIM 
The deletion of the RGG-box in pAc5.1-myc-mbmWT was performed exactly as described 
previously for pUASTattB-mbmWT using the same primers for SLIM-PCR (see 6.4.1.). The 
SLIM product was amplified via transformation and miniprep (see 6.1.6. and 6.1.7.). 
Sequencing (see 6.1.8.) using the pAc5.1 sequencing primers as well as the mbm-specific 
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reverse primer “mbm r34258” revealed two undesired mutations (S→P) in pAc5.1-myc-
mbmdRGG in comparison to mbm’s gene sequence retrieved from flybase.org (CG11604) and 
to pUAST-mbmdRGG. Both mutations were then also found in pAc5.1-myc-mbmWT generated 
in this work as well as in the gDNA extracted from the stable pAc5.1-myc-mbmWT S2 cell line 
which existed previously in our lab. Therefore, these unwanted mutations in both plasmids 
were corrected via two rounds of SLIM using the primers “SLIM T→C Exon 1 FS”, “SLIM 
T→C Exon 1 RS”, “SLIM T→C Exon 1 FT” and “SLIM T→C Exon 1 FT” in the first round 
and “SLIM T→C Exon 2 FS”, “SLIM T→C Exon 2 RS”, “SLIM T→C Exon 2 FT” as well as 
“SLIM T→C Exon 2 FT” in the second round (see Table 8). 
Further SLIM-PCRs were performed to substitute the first amino acid in mbm’s two zink 
finger domains (C354Y and C371Y) in pAc5.1-myc-mbmWT and pAc5.1-myc-mbmdRGG. 
Primers used were “SLIM ZnF1 FS”, “SLIM ZnF1 RS”, “SLIM ZnF1 FT” and “SLIM ZnF1 
RT” for C354Y and “SLIM ZnF2 FS”, “SLIM ZnF2 RS”, “SLIM ZnF2 FT” as well as “SLIM 
ZnF2 RT” for C371Y (see Table 8). 
 
6.7.3. Stable transfection into Drosophila S2R+ cells 
The plasmids pAc5.1-myc-mbmWT, pAc5.1-myc-mbmdRGG, pAc5.1-myc-mbmZnF and     
pAc5.1-myc-mbmdRGG,ZnF were transfected into Schneider S2 cells. To this end, S2R+ cells 
were cultured at 25 °C in full medium (Schneider’s Drosophila Medium (Biowest) 
supplemented with 10 % heat-inactivated fetal bovine serum (FBS; Biochrom AG) and 1 %  
penicillin/streptomycin (Invitrogen)) to a density of approximately 5 x 106 cells/ml. For each 
transfection, 1.8 x 106 cells were transferred into a well of a 6-well plate and the total volume 
per well was adjusted to 3 ml with full medium. The cells were grown overnight in 25 °C. The 
medium was aspirated and 2 ml of serum-free Schneider medium (SFM) was pipetted to each 
well. For each transfection, 100 µl of SFM were mixed with 8 µl Cellfectin (Invitrogen). In a 
second reaction tube, 3.6 µg of either pAc5.1-myc-mbmWT, pAc5.1-myc-mbmdRGG, pAc5.1-
myc-mbmZnF or pAc5.1-myc-mbmdRGG,ZnF as well as 0.8 µg pCoHygro (Invitrogen) were added 
to 100 µl SFM and mixed by vortexing. For each transfection, the tubes were mixed and 
incubated at RT for 30 min before 800 µl SFM were added. The SFM previously added to the 
cells was aspirated and the transfection mixtures were pipetted onto the cells. Following 
incubation at 25 °C for 5 h, the transfection medium was removed by aspiration and 3 ml full 
medium were added. The cells were grown at 25 °C for 3 days, then resuspended, pelleted at 
1,200 x g for 5 min, resuspended in 5 ml fresh full medium and transferred into a 25 ml cell 
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culture flask. The cell cultures were split 1:5 with fresh full medium every three to four days. 
After two weeks, full medium added to the cell cultures was supplemented with 0.2 µg/µl 
Hygromycin B Gold (InvivoGen) for the selection of successfully transfected cells. 
 
6.7.4. Long-term storage of S2R+ cells in liquid N2 
Aliquots of the stably transfected cell lines were stored in liquid nitrogen. The cell density 
was determined using a Neubauer improved cell counting chamber and the cells were pelleted 
at 1,200 x g for 5 min. The supernatant (conditioned medium) was transferred into a new tube 
and the cells were resuspended in 10 ml Dulbecco’s PBS (Biowest). Following centrifugation 
at 1,200 x g for 5 min, the supernatant was discarded and the cell pellet was resuspended in 
freezing medium (40 % conditioned medium, 40 % fresh full medium, 10 % heat-inactivated 
FCS (Biochrom AG), 10 % DMSO (Applichem)). The amount of freezing medium was 
adjusted to a final cell density of 1.1 x 107 cells/ml. The cell suspension was split into 1 ml 
aliquots in cryovials. The cryovials were wrapped into paper towels, placed in a Styrofoam 
box and frozen at -80 °C. After a week, the cryovials were transferred into a liquid nitrogen 
tank. 
To take frozen cells into culture, a cryovial was thawed at RT and the cell suspension was 
washed twice by centrifugation at 1,200 x g for 5 min, discarding the supernatant and 
resuspending in 10 ml Dulbecco’s PBS. After the second washing step, the cells were 
resuspended in 5 ml full medium and transferred into a 25 ml cell culture flask. For the first 
two weeks, the medium was aspirated and the cells were resuspended in fresh full medium. 
Then, hygromycin B selection was started as described previously (see 6.7.3.). 
 
6.8. RNA-binding assay 
The RNA-binding assay was adapted from E-Shehawi & Elseehy (2013) as well as Cornelia 
Engert, Master Thesis (2015) and used to investigate the ability of different Mbm mutants to 
bind to ribosomal RNA (rRNA) probes. To this end, myc-tagged Mbm proteins with either 
wild-type amino acid sequence (myc-MbmWT), a deleted RGG-box (myc-MbmdRGG), mutated 
zinc-fingers (myc-MbmZnF) or the double mutation (myc-MbmdRGG,ZnF) were expressed in 
Drosophila S2R+ cells and isolated via native immunoprecipitation (IP) as described earlier 
(see 6.2.2.). The protein concentrations of the IP products were estimated using a dot blot (see 
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6.2.3.2.). The digoxygenin-labeled rRNA probes needed for the assay were generated as 
described in section 6.8.1. 
 
6.8.1. Generation of digoxygenin-labeled rRNA probes 
In previous works, fragments of ribosomal DNA were amplified by PCR and cloned into 
pSTBlue-1 AccepTorTM vector (Novagen) for later in-vitro transcription into digoxygenin 
(DIG)-labeled rRNA probes (Prof. Dr. Thomas Raabe, AG Raabe; Cornelia Engert, Master 
Thesis, 2015). 
In the present study, the generation of DIG-labeled RNA probes was performed using the DIG 
Northern Starter Kit (Roche). The rDNA sequences for the different probes had been cloned 
into pTSBlue-1 using the restriction enzymes KpnI and SacI (Prof. Dr. Thomas Raabe, AG 
Raabe; Cornelia Engert, Master Thesis, 2015). The plasmids were linearized using either 
KpnI or SacI and the rDNA was in-vitro transcribed using either T7 or SP6 RNA polymerase 
(Roche). The restriction enzyme and RNA polymerase were chosen depending of the 
orientation of the rDNA insert in pTSBlue-1 so that sense-DIG-rRNA probes were generated. 
The DIG-labeling in-vitro transcription was performed according to the DIG Nothern Starter 
Kit’s manual. The labeling efficiency was also determined according to the kit’s manual using 
a Biodyne B Transfer (positively charged nylon) Membrane, 0.45 µm (PALL). Cross-linking 
was performed with a Hoefer UVC500 UV crosslinker by applying 120,000 µJ/cm² with UV 
light at a wavelength of 254 nm. 
 
6.8.2. RNA-binding assay 
80 ng of immunoprecipitated protein (see 6.6.1. and 6.6.2.) were mixed with 1.5 µl RNase 
inhibitor (Applied Biosystems) and the total volume was adjusted to 18.5 µl with RNA-
binding buffer. After incubation at RT for 5 min, 0.5 µl DIG-labeled rRNA probe (150 ng) 
were added to the sample and incubated at RT for 30 min. The bonds between rRNA 
molecules and proteins were stabilized by crosslinking on ice for 10 min using a UV 
closslinker (Hoefer UVC500). Unbound rRNA was digested by adding 1 µl RNase A (1 
µg/µl) and incubation at 37 °C for 15 min. The reaction was stopped and the probes were 
prepared for SDS-PAGE by mixing with 20 µl 2x Laemmli buffer. SDS-PAGE was 
performed as described earlier (see 6.2.4.), but 5 % glycerol were added to the separating gel 
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and DEPC-H2O was used to prepare all the solutions needed. Northwestern blot was carried 
out to visualize the rRNA-protein hybrids separated by SDS-PAGE (see 6.2.6.). 
 
6.9. Demethylation assay 
To investigate the methylation status of MbmdRGG in comparison to MbmWT expressed in 
S2R+ cells, demethylation assays were performed (adapted from Chen et al., 2004). Stable 
S2R+ cell lines expressing myc-MbmWT or myc-MbmdRGG as well as untransfected S2R+ cells 
were grown to a density of approximately 5 x 106 cells/ml. The cells were resuspended and 5 
ml of each cell line were evenly split into two wells of a 6-well plate. To one well of each cell 
line, 500 µl full medium (see 6.7.3.) supplemented with 10 µM adenosine dialdehyde (AdOx) 
were added. Following incubation at 25 °C for 5 h, IP was performed using 5 µl mouse anti-
myc 9E10 antibody (Santa Cruz Biotechnology) as described previously (see 6.2.1.). The IP 
products were subjected to SDS-PAGE (see 6.2.4.) followed by western blot (see 6.2.5.) using 
the primary antibodies anti-myc 9E10, anti-mbm95, anti-sDMA SYM11 (anti-symmetrical 
dimethylated arginines) and anti-aDMA ASYM24 (anti-asymmetrical dimethylated arginines; 
see Table 9). 
 
6.10. Methylation assay 
By methylation assay, it was attempted to investigate the ability of Drosophila arginine 
methyl transferases 1 and 5 (DART1 & DART5) to methylate Mbm’s RGG-box. To this end, 
total RNA was extracted from w1118 flies using a Total RNA Extraction Kit (Applied 
Biosystems). Ten female flies were homogenized in 400 µl lysis buffer (supplied by the kit) 
and RNA was extracted according to the kit’s protocol. The RNA was reverse transcribed 
using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) following its 
protocol. Using the cDNA as a template, the genes dart1 and dart5 were amplified by PCR 
(see 6.1.2.) at an annealing temperature of 66 °C using the primers “EcoRI-Dart1 fwd” and 
“Dart1-XhoI rev” for dart1 and “EcoRI-Dart5 fwd” and “Dart5-XhoI rev” for dart5. Thereby, 
an EcoRI restriction site was added at the 5’ end and an XhoI restriction site was added at the 
3’ end of both genes. Both constructs were cloned into pMT/V5-His A, a CuSO4-inducable 
transfection vector (Invitrogen), using EcoRI-HF and XhoI restriction enzymes (see 6.1.5.) 
and thereby fusing the genes to a His6-tag. The newly generated plasmids were amplified, 
isolated and verified by sequencing as described earlier (see 6.1.6. through 6.1.9). 1 µg of 
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both plasmids was transiently transfected into the stable pAc5.1-myc-mbmWT and pAc5.1-
myc-mbmdRGG S2R+ cell lines generated previously (see 6.7.). The transient transfection was 
carried out like the stable transfection (see 6.7.3.), but without cotransfection of pCoHygro. 
The transfected cells were grown in full medium for two days and then the expression of his6-
dart1 or his6-dart5 was induced by adding 350 µM CuSO4. Following 24 h of incubation, the 
cells were pelleted by centrifugation at 1,200 x g and 4 °C for 5 min, the pellet was 
resuspended in 10 ml cold Dulbecco’s PBS (Biowest) and pelleted again at 1,200 x g and 4 °C 
for 5 min. The cells were lysed by resuspension in 60 µl 1x Laemmli and heating to 95 °C for 
10 min. SDS-PAGE and western blot were performed as described earlier (see 6.6.4. and 
6.6.5.), using the antibodies anti-myc 9E10, anti-His6 HIS.H8, SYM11 and ASYM24 (Table 
9). 
 
6.11. Puromycin assay 
Puromycin is an aminoacyl-tRNA analog that can be incorporated into newly synthesized 
proteins, thereby terminating the translation (Nathans, 1964; Nakano and Hara, 1979; Hansen 
et al., 1994). It is therefore used in Puromycin assays to investigate protein synthesis rates in 
Drosophila larval tissues ex vivo (adapted from Schmidt et al., 2009, Deliu et al., 2017).  15 
larvae were inverted in Schneider’s Drosophila Medium (Biowest) supplemented with 10 % 
heat-inactivated FBS (Biochrom AG) by opening their posterior end with forceps and turning 
them inside-out. The inverted larvae were then transferred into 1.5 ml reaction tubes 
containing Schneider medium with 10% FBS and 10 µg/ml puromycin. A negative control 
was additionally supplemented with 100 µg/ml cycloheximide and incubation of all samples 
was carried out on a rotator at RT for 40 min. The inverted larvae were then transferred into 
ice-cold PBS, the brains were dissected and immediately transferred into 10 µl 2x Laemmli 
buffer. SDS-PAGE and western blot were performed (see 6.2.4. and 6.2.5.) and newly 
synthesized proteins with incorporated puromycin could be detected with anti-puromycin 
12D10 antibody (Table 9). 
 
6.11.1. Quantification of puromycin assays 
The signal intensity of the western blots of four independent experiments was quantified with 
Fiji (ImageJ) using its gel analysis function. For each genotype or treatment, the total intensity 
of the whole lane on the blots was measured, normalized to the loading control (α-Tubulin) 
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and plotted relative to the intensity of puromycin-treated w1118 larval brains. Statistical 
analysis was done in R by a Wilcoxon-Rank-Sum (Mann-Whitney-U) test. 
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7. Results 
7.1. Deletion of Mbm’s RGG-box 
For the generation of mbmdRGG mutant flies as well as the expression of MbmdRGG in 
Drosophila S2R+ cells, mbm was cloned into the pUASTattB or pAc5.1-myc vector, 
respectively, and the RGG-box was deleted. Mbm’s RGG-box was defined including one    
di-RGG and one di-RG motif in close proximity (Figure 15). The single RGG downstream of 
the di-RG motif was also included in the deletion. 
 
Figure 15: Definition of Mbm’s RGG-box 
Mbm’s RGG-box was defined including one di-RGG (red) and one di-RG motif (green). A single RGG (blue) in 
close proximity to the di-RG motif was also included in the deleted part. 
 
Sequencing analysis showed the successful deletion of the RGG-box, spanning base pairs    
247 – 342 of mbm’s coding sequence (Figure 16). 
 
Figure 16: Sequencing results showing the RGG-deletion 
The sequence coding for Mbm’s RGG-box was deleted by SLIM-PCR and sequencing results were aligned with 
wild-type mbm (flybase.org) to verify the desired deletion. Shown here is an excerpt of the sequencing results 
including the deletion of base pairs 247 – 342 of mbm’s coding sequence. Stars indicate matching base pairs and 
dashes missing base pairs in mbmdRGG in comparison to mbm. 
 
 
7.2. Phenotypical characterization of mbmdRGG mutant flies 
7.2.1. Viability is decreased in flies expressing mbmdRGG and mbmZnF 
The ability of the mbmdRGG and mbmZnF transgenes to rescue the lethality of mbmSH1819 was 
investigated. Two independent fly lines carrying the mbmZnF transgene and three independent 
fly lines carrying the mbmdRGG transgene crossed into the mbmSH1819 background were tested 
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in survival assays (see 6.4.3. and 6.5; Figure 17). While the wild-type line w1118 showed    
85.1 ±10.1 % of larvae reaching pupal stage and 81.1 ±8.5 % of larvae reaching adulthood, 
the viability of mbm null mutant larvae is significantly decreased with 44.3 ±16.6 %              
(p = 0.012) reaching the pupal stage and 0 % reaching adulthood (p = 0.007). mbmSH1819; 
mbmWT rescues the ability to reach the pupal stage (86.8 ±10.7 %), but significantly fewer 
larvae (45.1 ±15.1 %; p = 0.014) reach the adult stage. Thus, viability in mbmSH1819; mbmWT is 
not fully rescued. In the two zinc-finger mutant lines mbmSH1819; mbmZnF 2-1M and 2-3M, few 
larvae reach the pupal stage (10.8 ±11.9 %; p = 0.012 and 21.1 ±9.9 %; p = 0.012, 
respectively) and only some pupated larvae finally reach adulthood (3.4 ±5.9 %, p = 0.014 
and 2.3 ±6.1 %, p = 0.007, respectively). Interestingly, pupation rates in the zinc-finger 
mutants are also significantly decreased compared to mbmSH1819 (p = 0.014 for mbmZnF 2-1M 
and p = 0.03 for mbmZnF 2-3M; see red asterisks in Figure 17). The deletion of Mbm’s RGG-
box has a less severe effect on pupation rates in all three independent mbmdRGG mutant lines, 
but in the dRGG mutant lines M1 and M4 they are still significantly lower compared to w1118 
(M1: 58.0 ±14.5 %, p = 0.048; M3: 65.2 ±12.9 %, p = 0.078; M4: 51.1 ±17.2 %, p = 0.018). 
However, only few escapers reach adulthood (M1: 2.0 ±4.9 %, p = 0.021; M3: 0.6 ±1.5 %,     
p = 0.007; M4: 0.6 ±1.5 %, p = 0.007). 
For all further experiments, only mbmSH1819; mbmZnF 2-1M and mbmSH1819; mbmdRGG M1 were 
used, then simply referred to as mbmSH1819; mbmZnF and mbmSH1819; mbmdRGG, respectively. 
 
Results 
60 
 
 
Figure 17: Results of the viability assays 
The development of the larvae was monitored for two weeks after larval hatching. Seven independent 
experiments were performed and survival rates were averaged. The percentage of larvae that pupated (dark grey 
bars) and larvae that finally reached adulthood (light grey bars) is shown here. The numbers in the dark grey bars 
indicate the overall number of larvae used per genotype. The black asterisks indicate significant difference in 
comparison to w1118, red asterisks indicate significance compared to mbmSH1819 (* p < 0.05, ** p < 0.01, n.s. = not 
significant). 
 
7.2.2. Mbm is delocalized in dRGG and ZnF mutant larval neuroblasts 
In wild-type larval neuroblasts, Mbm is localized to the nucleolus. To investigate possible 
effects on Mbm localization caused by the mbmdRGG and mbmZnF mutations, larval brains were 
dissected and immunostained with antibodies against Mbm, neuroblast markers Miranda 
(Mir) and aPKC as well as the nucleolar marker dNop5 (Figure 18). In w1118 and the rescue 
line mbmSH1819; mbmWT, Mbm is localized to the nucleolus while it is completely absent in the 
null mutant mbmSH1819 as it was reported previously (Hovhanyan et al., 2014). The rescue line 
shows that genomic mbm constructs inserted in position 65B2 in the 3rd chromosome are 
generally able to be expressed and localized correctly. In mbmSH1819; mbmdRGG, in which Mbm 
is expressed without its RGG-box, Mbm is also present in the nucleolus, but partially 
delocalized to the nucleus. In contrast, in the zinc-finger mutant mbmSH1819; mbmZnF, Mbm is 
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completely delocalized to the cytoplasm. The aPKC staining was barely visible in contrast to 
the very strong staining of dNop5 on the same channel, but neuroblasts could still be 
determined by staining of Miranda. 
 
Figure 18: Mbm is delocalized in dRGG and ZnF mutant neuroblasts 
Interphase neuroblasts were stained for neuroblast marker aPKC and nucleolar marker dNop5 (green), Mbm 
(red) as well as neuroblast marker Miranda (Mir, blue). Representative images are shown here. Mbm is located 
in the nucleus in w1118 and the rescue line mbmSH1819; mbmWT, while it is absent in the null mutant mbmSH1819, 
partially delocalized to the nucleus in the RGG-mutant mbmSH1819; mbmdRGG and fully delocalized to the 
cytoplasm in the zinc-finger mutant mbmSH1819; mbmZnF. The aPKC staining is barely visible in contrast to the 
strong staining of dNop5.  
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7.2.3. Neuroblast cell size is significantly decreased in dRGG mutants 
Since it was reported previously that neuroblasts are significantly smaller in the mbm null 
mutant mbmSH1819 (Hovhanyan et al., 2014), NB cell sizes in mbmdRGG and mbmZnF mutant 
larval brains were measured (see 6.6.1.). Neuroblasts were measured regardless of their cell 
cycle state. NBs in the mbm null mutant were significantly smaller (94.2 ±26.2 µm²;               
p = 0.0012; n = 203) compared to w1118 (104.2 ±26.4 µm²; n = 169). Similarly, the dRGG 
mutant mbmSH1819; mbmdRGG showed significantly smaller NB sizes (97.5 ±22.4 µm²;              
p = 0.032; n = 205). NB sizes in mbmSH1819; mbmZnF were found to not be significantly 
different to the wild-type (105.4 ±18.4 µm²; p = 2.44; n = 212) which is consistent with the 
findings in an earlier work (Cornelia Engert, Master Thesis, 2015). The neuroblasts in the 
rescue line are also not significantly different to w1118 (102.0 ±29.7 µm²; p = 1.88; n = 157; 
Figure 19).  
 
 
Figure 19: Neuroblast size is significantly decreased in mbmdRGG mutants 
Neuroblasts in mbmSH1819 are significantly smaller (p = 0.0012) compared to w1118 (as reported in Hovhanyan et 
al., 2014). Similarly, significantly smaller NBs were found in mbmdRGG mutants (p = 0.032). Neuroblast size in 
the zinc-finger mutant mbmSH1819; mbmZnF and in the rescue line mbmSH1819; mbmWT are not significantly different 
to w1118 (p = 2.44 and p = 1.41, respectively). (* = p < 0.05; ** = p < 0.01; n.s. = not significant). 
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Additionally, total brain size was observed to be visibly reduced in mbmSH1819 and   
mbmSH1819; mbmZnF 3rd instar larvae, but no measurements were carried out. In         
mbmSH1819; mbmdRGG larvae, however, total brain size does not seem to be reduced. 
 
7.3. The role of Mbm’s RGG-box in ribosome biogenesis 
7.3.1. MbmdRGG shows decreased binding of ribosomal RNA 
In an earlier work it was suggested that Mbm plays a role in ribosome biogenesis, since it 
could be shown that Mbm influences the processing of ribosomal RNA (rRNA) (Hovhanyan 
et al., 2014). This finding raises the question which protein domain of Mbm is capable of 
binding rRNA, enabling an interaction between the protein and the RNA. Two likely 
candidates are Mbm’s RGG-box as well as its zinc-finger domains. In order to shed light into 
these domains’ rRNA-binding capabilities, RNA-binding assays were performed using myc- 
tagged Mbm constructs with either wild-type Mbm sequence (myc-MbmWT), a deleted RGG-
box (myc-MbmdRGG), mutated zinc-fingers (myc-MbmZnF) or a double mutant (myc-
MbmdRGG,ZnF) expressed in Drosophila S2R+ cells. The rRNA probes used in this experiment 
are depicted in (Figure 20).  
 
Figure 20: Structure of the rDNA and locations of the rRNA probes. 
The rDNA of Drosophila melanogaster contains the genes for the 18S, 5.8S, 2S and 28S rRNAs (boxes) that are 
part of the ribosomal subunits. Upstream of the 18S DNA lies an external transcribed spacer (ETS), the internal 
transcribed spacer 1 (ITS1) is located in between 18S and 5.8S rDNA and the internal transcribed spacer 2 
(ITS2) lies in between 2S and 28S rDNA. Below the rDNA strand, the fragments are shown which were in-vitro 
transcribed into rRNA probes including their designation used in this work (figure adapted from Cornelia Engert, 
Master Thesis, 2015). 
 
In the binding assay, all rRNA probes show weaker binding to myc-MbmdRGG compared to 
myc-MbmWT, which is mostly evident in the case of ITS1. Surprisingly, ETS, ITS1 and ITS2 
show stronger binding to the zinc-finger mutant myc-MbmZnF compared to the wild-type 
construct and this effect is increased even further in the double mutant myc-MbmdRGG,ZnF 
(Figure 21A). The loading control (Figure 21C) shows that all myc-Mbm constructs were 
approximately evenly applied and that differences in Figure 21A are not caused by uneven 
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loading. myc-Mbm was expected to run at approximately 100 kDa, however, additional 
protein bands are visible at ~200 and ~300 kDa, which cannot be explained by truncated 
protein. Thus, a control blot of myc-MbmWT bound to ITS1 was detected with anti-Mbm 
EP031195 antibody to see whether these bands are caused by the binding of two or three 
Mbm proteins to one rRNA molecule. Probing northwestern blots with anti-Mbm proved 
difficult, but weak bands are visible at ~200 and ~300 kDa, indicating Mbm dimers and 
trimers (see Figure 21B). In contrast, in the loading control with the same amounts of protein 
samples but without rRNA probes, these two upper bands do not appear (Figure 21C). 
 
Figure 21: rRNA-binding is decreased in myc-MbmdRGG, increased in myc-MbmZnF and the double 
mutant 
myc-Mbm constructs were expressed in S2R+ cells and purified by IP for RNA-binding assays with DIG-
labelled rRNA probes. A All rRNA probes show weaker binding to myc-MbmdRGG in comparison to myc-
MbmWT with the biggest difference found in the case of ITS1. myc-MbmZnF shows stronger binding of the rRNA 
probes, while the double mutant myc-MbmdRGG,ZnF appears to have the strongest binding affinity to all rRNA 
probes except 18S2. B The bands at ~200 and ~300 kDa seem to be dimers and trimers of Mbm verified by 
detection with anti-Mbm (indicated by arrows). C The same volume of each protein sample used for the binding 
assay was used as a loading control (without rRNA probes), showing that all samples were approximately evenly 
applied. 
 
7.3.1.1. Investigation of the methylation status of Mbm’s RGG-box 
Since the methylation status of RG/RGG domains is important for their RNA-binding 
capabilities (Blackwell et al., 2010), it was investigated whether Mbm is methylated within its 
RGG-box. To this end, myc-MbmWT and myc-MbmdRGG constructs were expressed in 
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Drosophila S2R+ cells and purified by immunoprecipitation using anti-myc 9E10 antibodies. 
Western blots were performed using antibodies against symmetrically and asymmetrically 
dimethylated arginines (SYM11 and ASYM24 antibodies, respectively). As a negative 
control, cells were treated with AdOx, a methylation inhibitor. No asymmetric dimethylation 
could be observed. However, MbmWT was found to be symmetrically dimethylated, while no 
methylation occurred in MbmdRGG (Figure 22). Thus, Mbm seems to be symmetrically 
dimethylated within its RGG-box in S2R+ cells. Unfortunately, these results could not be 
replicated and can therefore only be seen as a hint. 
 
Figure 22: Mbm might be methylated within its RGG-box 
Immunoprecipitated myc-MbmWT expressed in S2R+ cells shows symmetric dimethylation (SYM11) which is 
reduced upon AdOx treatment. No asymmetric dimethylation (ASYM24) was observed in myc-MbmWT. In myc-
MbmdRGG, neither symmetric nor asymmetric dimethylation was found. Untransfected S2R+ cells were used as a 
control for specificity of the IP. Unfortunately, these results could not be replicated. 
 
7.3.1.2 Investigation of Mbm methylation mediated by Dart1 and Dart5 
The methylation status of Mbm’s RGG-box might be important for its RNA-binding 
capabilities. Darts1 and Dart5 were assumed to be the most promising candidates for the 
regulation of protein-RNA binding by asymmetric or symmetric methylation of RGG-boxes, 
respectively (see 3.3.1.). Therefore, forced methylation of myc-Mbm by overexpression of 
Dart1 and Dart5 was attempted in Drosophila S2R+ cells. Total cell lysates were used for 
western blots and symmetric or asymmetric dimethylation was detected by SYM11 or 
ASYM24 antibodies, respectively (Figure 23). Successful expression of the myc-Mbm 
constructs and His6-Dart1 or Hi6-Dart5 was ensured by detection with anti-myc 9E10 or anti-
His6 HIS.H8 antibodies, respectively (see 6.10.). No symmetric dimethylation of myc-Mbm
WT 
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or myc-MbmdRGG was found. By detection with ASYM24, several bands can be seen at the 
approximate size of myc-Mbm, but they were also found in the cell lysate of untransfected 
S2R+ cells, showing unspecific detection. Based on these results, it seems that myc-Mbm 
cannot be methylated by His6-Dart1 or His6-Dart5 in Drosophila S2R+ cells. 
 
Figure 23: Mbm is not methylated in Drosophila S2R+ cells upon Dart1 or Dart5 overexpression 
myc-MbmWT and myc-MbmdRGG were co-expressed with His6-Dart1 or His6-Dart5 in Drosophila S2R+ cells. 
Total cell lysates were used for western blots. Detection with anti-His6 HIS.H8 antibodies ensured the expression 
of His6-Dart1 (~46 kDa) or His6-Dart5 (~75 kDa). Expression of myc-Mbm constructs was ensured by detection 
with anti-myc 9E10 antibodies. Detection with SYM11 antibodies revealed no symmetric methylation of both 
myc-Mbm constructs. ASYM24 antibodies detected several unspecific bands at the approximate size of myc-
Mbm which are also present in cell lysate of unstransfected S2R+ cells. Thus, no asymmetric methylation 
occured in both myc-Mbm constructs. 
 
7.3.2. Ribosomal protein RpS6 is partially delocalized in Mbm null, dRGG and ZnF 
mutant neuroblasts 
The findings that mbmdRGG and mbmZnF mutations influence Mbm’s rRNA-binding 
capabilities, raised the question whether ribosome biogenesis is affected in these mutant fly 
lines. This might be reflected in failure of ribosomal subunit transport. In an earlier work, a 
localization defect of RFP-tagged RpS6, a small ribosomal subunit protein, was found in 
neuroblasts of the mbm null mutant mbmSH1819 (Hovhanyan et al., 2014). Localization of the 
large ribosomal subunit protein RpL11, in contrast, was not affected. Thus, the influence of 
mbmdRGG and mbmZnF mutations on RpS6 localization in L3 larval neuroblasts was 
investigated by immunostainings with anti-RpS6 54D2 antibodies (Figure 24). In w1118, 
RpS6 is localized in the cytoplasm and the nucleolus, while in the mbmSH1819 RpS6 staining 
could only be observed in the cytoplasm. In the rescue line mbmSH1819; mbmWT, this phenotype 
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is reverted to a wild-type-like state. mbmSH1819; mbmdRGG and mbmSH1819; mbmZnF, however, 
do not show nucleolar RpS6 staining. 
 
Figure 24: RpS6 is partially delocalized in mbm null, dRGG and ZnF mutant neuroblasts 
In w1118 and mbmSH1819; mbmWT (rescue) neuroblasts, anti-RpS6 staining (green) was found in the cytoplasm and 
the nucleolus whereas in the Mbm (red) mutant fly lines mbmSH1819, mbmSH1819; mbmdRGG and mbmSH1819; mbmZnF 
RpS6-staining could only be observed in the cytoplasm. aPKC and dNop5 (blue) were used as a neuroblast or 
nucleolar marker, respectively. 
 
These results contradict the findings from Hovhanyan et al. (2014), where RFP-RpS6 was 
found to be localized only in the cytoplasm in the wild-type background and mostly in the 
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nucleolus in the mbm null mutant background. Therefore, it was attempted to replicate their 
approach. UAS-mRFP::RpS6 was expressed in a wild-type and an mbm null mutant 
background by the neuroblast-specific driver Mz1060-Gal4. Since autofluorescence of 
RFP::RpS6 was insufficient, immunostainings with anti-RFP and anti-RpS6 antibodies were 
performed. Staining against RpS6 showed nucleolar and cytoplasmic localization in the wild-
type background, but only cytoplasmic localization in the mbm null mutant background 
(Figure 25 A). These results are consistent with those shown in Figure 24. The anti-RFP 
antibody, however, does only exhibit cytoplasmic staining in both the wild-type and mbm null 
mutant background (Figure 25 B). Yet, mRFP-RpS6 might not reflect the behavior of the 
endogenous RpS6 protein. 
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Figure 25: mRFP::RpS6 is not translocated to the nucleolus 
A Upon neuroblast specific overexpression of UAS-mRFP::RpS6 by Mz1060-Gal4, RpS6 staining (red) showed 
nucleolar and cytoplasmic localization in the wild-type background and only cytoplasmic localization in the 
mbm null mutant background (Mbm in green; results consistent with Figure 24). aPKC was used as a neuroblast 
and dNop5 as a nucleolar marker (blue). B Anti-RFP staining (red) revealed only cytoplasmic localization in 
both the wild-type and the mbm null mutant background (Mbm in green). Miranda (Mir) was used as a 
neuroblast and fibrillarin (Fib) as a nucleolar marker (blue). 
 
7.3.3. Protein synthesis is increased in mbmSH1819; mbmdRGG mutant larval brains 
The findings that rRNA processing is affected in mbm null mutants (Hovhanyan et al., 2014) 
and that the small ribosomal subunit protein RpS6 is partially delocalized in mbm null, dRGG 
and ZnF mutant neuroblasts raised the question whether ribosome function is also affected. 
To elucidate ribosome function in these mutants, protein synthesis rates in larval brains were 
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investigated by puromycin labeling (Deliu et al., 2017; see 6.11.). Inverted L3 larvae were 
incubated with puromycin in Schneider medium, brains were dissected, lysed and subjected to 
Western blots using anti-Puromycin 12D10 antibodies (Figure 26). In w1118, anti-Puromycin 
detection is mildly increased in puromycin-treated compared to untreated larval brains. Co-
incubation with cycloheximide, a protein synthesis inhibitor, abolishes puromycin 
incorporation, verifying puromycin labeling as a read-out for protein synthesis rates. In larval 
brains of the mbm null mutant mbmSH1819, protein synthesis rates appear to be similar 
compared to the wild-type line w1118. In the rescue line mbmSH1819; mbmWT and the zinc-finger 
mutant mbmSH1819; mbmZnF, however, protein synthesis rates are slightly increased and in the 
dRGG mutant mbmSH1819; mbmdRGG, protein synthesis rates seem to be strongly increased 
compared to the wild-type. 
 
Figure 26: Protein synthesis 
rate is increased in mbmdRGG 
mutant larval brains 
Inverted 3rd instar larvae were 
treated with puromycin (Puro), 
thereby labeling newly 
synthesized proteins and 
allowing detection with anti-
Puro antibodies. Western blots 
revealed an increase in protein 
synthesis in mbmSH1819; 
mbmdRGG mutants. Detection 
with anti-Tubulin was used as 
a loading control. 
 
 
The signal intensity of the Western blots of four independent experiments was quantified with 
Fiji (see 6.11.1.). Each genotype or treatment was compared to puromycin-treated w1118 larval 
brains (Figure 27). Upon co-incubation with cycloheximide (CHX), the relative intensity 
(0.31 ±0.16) is nearly back to untreated levels (0.15 ±0.15), verifying puromycin labeling as a 
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valid measure for protein synthesis rates. In the mbm null mutant line mbmSH1819, the protein 
synthesis rate is nearly at the same level as in w1118 (1.23 ±0.53). In the zinc-finger mutant 
mbmSH1819; mbmZnF, the protein synthesis rate seems to be roughly doubled (2.26 ±1.24). 
Surprisingly, in the mbmSH1819; mbmdRGG mutant fly line, protein synthesis rates are on 
average almost four times higher than in w1118 (3.75 ±1.62; p = 0.021). The rescue line 
mbmSH1819; mbmWT also shows approximately doubled protein synthesis rates (2.04 ±0.29). 
 
Figure 27: Quantification of puromycin labeling western blots 
Signal intensity on western blots of four independent puromycin labeling experiments was measured and plotted 
relative to the intensity of puromycin-treated w1118 3rd instar larval brains. Protein synthesis rates are significantly 
increased in mbmdRGG mutant larval brains (p = 0.021). 
 
 
7.4. Influence of mbmdRGG on the TOR pathway 
Hovhanyan et al. (2014) proposed a possible role of Mbm in the TOR pathway. In the present 
work, the puromycin assays (see 7.3.3.) showed increased protein synthesis rates in mbmdRGG 
mutant larval brains which might be caused by changes in TOR signaling. To investigate 
whether expression of genes involved in TOR signaling is increased in mbmdRGG mutant larval 
brains, qPCRs for tor, akt and s6k were performed. rp49 was used as the housekeeping gene. 
No significant differences in expression levels of tor, akt and s6k could be found in any of the 
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mbm mutant flies compared to w1118. However, only three biological replicates could be tested 
so far. tor expression in mbmdRGG larval brains is close to a significant increase (3.58 ±1.4 fold 
expression; p = 0.06) and it might also be slightly increased in mbmZnF mutants (2.27 ±0.82) 
while there is nearly no change in mbmSH1819 mutants (1.06 ±0.11 fold expression). In the 
rescue line mbmWT, mean tor expression levels are nearly unchanged, but vary quite a bit 
between biological replicates (1.21 ±0.63; Figure 28A). In the case of akt expression levels, 
high variability in biological replicates but no significant differences were found between 
w1118 and the mbm mutant larval brains (Figure 28B). s6k expression levels also show no 
significant differences, but a high variability between the three samples, especially for 
mbmdRGG (4.2 ±4.2 fold expression; Figure 28C). 
 
 
Figure 28: The TOR pathway might be affected in 
mbmdRGG mutants 
qPCRs were performed from total RNA of larval brains 
using three biological replicates. A tor expression level 
in mbmdRGG mutants is significantly increased from 
w1118. B No significant differences but high variabilities 
were found for akt expression levels in mbm mutants 
compared to w1118. C s6k expression might be increased 
in mbmSH1819, mbmdRGG and mbmZnF, but no significance 
was reached. 
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8. Discussion 
In earlier studies, functions of Mbm in brain development and neuroblast proliferation in 
Drosophila were investigated using the hypomorphic mutation mbm1 and the null mutation 
mbmSH1819 (Raabe et al., 2004; Hovhanyan et al., 2014). Mbm was identified as a nucleolar 
protein involved in neuroblast proliferation. In mbm null mutants, smaller NB sizes and fewer 
NB progeny cells were found as well as an effect on rRNA processing and the localization of 
ribosomal protein RpS6. Furthermore, Mbm was shown to be a transcriptional target of Myc 
and it might therefore be regulated by the insulin/TOR pathway. These results led to the 
suggestion that Mbm might be implicated in ribosome biogenesis, thereby regulating NB 
proliferation (Hovhanyan et al., 2014). Mbm’s exact functions, however, remained unclear. 
Mbm features an RGG-box (N-terminal) and two zinc-finger domains (C-terminal; see Figure 
9 and Figure 15) which are candidates for possible rRNA binding domains. Flies expressing a 
genomic mbm construct with mutated zinc-fingers (mbmZnF) were generated and investigated 
in an earlier study (Cornelia Engert, Master Thesis, 2015). Preliminary analyses performed on 
these mutant larval brains showed no effects on NB size and no binding of C-terminal Mbm 
constructs (expressed in E. coli) to rRNA probes in vitro, suggesting that the zinc-finger 
domains are not important for a possible role in ribosome biogenesis. The N-terminal half of 
Mbm, however, was shown to bind to rRNA probes, meaning that the RGG-box might be 
involved. 
In the present study, the function of Mbm’s RGG-box was investigated in in vivo and in vitro 
experiments. Additionally, the zinc-finger mutant was included in most experiments to further 
elucidate this domain’s functions. 
 
8.1. The RGG-box and zinc-fingers are important for Mbm’s functions 
The effect of the deletion of Mbm’s RGG-box was first tested in vivo by survival assays 
(Figure 17). As it was reported previously (Hovhanyan et al., 2014), the mbm null mutant 
mbmSH1819 showed decreased survival until and lethality during pupal stage. While 
approximately 60 % of the mbmdRGG mutant larvae of all three independent lines pupated, 
which is a significant decrease in the transgenic lines mbmdRGG M1 and mbmdRGG M4 
compared to w1118 (~85 % pupation rate), only very few adult flies eclosed. This suggests that 
Mbm function does indeed rely on its RGG-box during larval stage, but even more during 
pupal stage. However, it cannot be excluded that the less severe effect of the mbmdRGG 
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mutation on larval viability is caused by a maternal effect. Only 35% of maternal mRNAs 
were reported to be degraded during the maternal-to-zygotic transition in the embryo (Tadros 
and Lipshitz, 2009; Cui et al., 2016), thus one could speculate that some maternal mRNAs 
persist into the larval stages. On the other hand, reduced survival of the rescue line mbmSH1819; 
mbmWT until adulthood implies that full rescue of the mbmSH1819 phenotype by genomic mbm 
constructs inserted into the 3rd chromosome in position 65B2 is not possible. The reason for 
this is unclear, but it could be due to insufficient expression levels or the expression pattern of 
the genomic mbm constructs. In the future, this should be investigated by qPCR analysis or by 
Western blotting. Nonetheless, this might enhance the effects of mbmdRGG and mbmZnF 
mutations during pupal stage. Mbm’s role during pupal stage, however, remains elusive. So 
far, Mbm was only shown to have functions in neuroblasts (Hovhanyan et al., 2014; personal 
communication: Thomas Raabe), which build up the adult CNS throughout embryonic and 
larval stages and then disappear during pupal stage (see 3.1.; reviewed in Harding and White, 
2018). In the present study, it was furthermore observed that mbmSH1819; mbmdRGG flies often 
seem to develop normally in the pupae and then die shortly before or even during eclosion. 
Thus, Mbm might play a role in locomotor control during eclosion, but it is also possible that 
deficits in brain development caused by the mbmdRGG mutation impedes the ability to eclose. 
Apart from these observations, this study mainly focuses on Mbm’s functions during larval 
stage. 
In the case of pupation rates, there seems to be a slight improvement in the three mbmdRGG 
mutant lines (M1: ~58 %; M3: ~65 %; M4: ~51 %) compared to the null mutant mbmSH1819 
(~44 %). This suggests at least a partial ability of MbmdRGG to rescue the mbmSH1819 
phenotype. Thus, Mbm might retain some of its functions even without its RGG-box, but the 
impact of the mutation during larval stages is still severe. 
Additionally, two zinc-finger mutant lines (mbmSH1819; mbmZnF 2-1M and 2-3M) were 
included in the rescue experiments. Surprisingly, survival rates during larval stages were 
significantly decreased even compared to the mbm null mutant. Thus, the mbmZnF mutation 
has a worse effect than Mbm not being present at all. A highly speculative explanation for this 
could be that the two amino acid substitutions in MbmZnF lead to a misfolding of the protein, 
thereby facilitating or blocking interaction of another motif with DNA, RNA or other 
proteins. This is supported by the results of the rRNA-binding assays (Figure 21) showing 
that myc-MbmZnF and the double mutant myc-MbmdRGG,ZnF exhibit stronger binding to rRNA 
probes than myc-MbmWT and myc-MbmdRGG. MbmZnF might therefore interfere with rRNA 
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processing or possibly with the translation of certain mRNAs (discussed in more detail in 
8.2.1.). 
Moreover, both MbmdRGG and MbmZnF were found to be mislocalized in 3rd instar larval 
neuroblasts (Figure 18). Mbm was previously reported to be a nucleolar protein (Hovhanyan 
et al., 2014), but while this is the case for w1118 and mbmSH1819; mbmWT larval NBs, in 
mbmdRGG mutants Mbm is partially delocalized to the nucleus. In mbmZnF mutants, on the 
other hand, Mbm is fully delocalized to the cytoplasm. Thus, both motifs seem to be 
important for correct localization of Mbm. For RGG-boxes, roles in protein translocation have 
been reported previously. For example, vertebrate nucleolin was shown to depend on its 
RGG-box for nucleolar localization (Ginisty et al., 1999; Pellar and DiMario, 2003) and 
human hnRNP A2 is partially delocalized from the nucleus to the cytoplasm when its RGG-
box is deleted (Nichols et al., 2000). For zinc-finger motifs the situation is less clear. 
Localization defects in zinc-finger mutants were reported for mammalian EEA1 which 
contains a FYVE type zinc-finger (Stenmark et al., 1996) and for mammalian JAZ which 
contains a C2H2 zinc-finger (Yang et al., 1999). For C2HC type zinc-fingers like in Mbm, 
however, no reports regarding zinc-finger dependent protein localization were found. 
Furthermore, it can’t be excluded that the mislocalization of MbmdRGG and MbmZnF is only 
caused by conformational changes of the protein induced by the mutations, thereby blocking 
other protein domains or making them accessible. In an earlier study, Mbm localization to the 
nucleolus was shown to depend on phosphorylation of its acidic clusters AC-1 and AC-2 by 
the kinase CK2α (Hovhanyan et al., 2014). Upon knock-down of CK2α or mutation of the 
phosphorylation sites, Mbm was partially delocalized to the cytoplasm. Possibly, defects in 
protein folding of MbmZnF and MbmdRGG might impede the interaction with CK2α and might 
therefore be a factor in the mislocalization. However, other factors have to be involved, since 
even the mutation of Mbm’s phosphorylation sites AC-1 and AC-2 did not lead to a full 
delocalization to the cytoplasm in contrast to the zinc-finger mutation. One could try to solve 
this problem by generating and investigating different RGG and zinc-finger mutants. For 
example, instead of deleting the whole RGG-box, one could substitute the arginines in the 
RG/RGG motifs with another amino acid. In the MbmZnF mutants, which were generated in an 
earlier work (Cornelia Engert, Master Thesis, 2015), the first cysteine of both zinc-finger 
motifs was substituted with tyrosine. However, the aromatic side chain of tyrosine is 
hydrophobic and bigger compared to the one of cysteine, which might induce defects in 
protein folding. Possibly, a smaller amino acid like glycine might be a better choice. In the 
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case that the sulfide residue of cysteine is important for Mbm’s structure through disulfide 
bridges, however, methionine might be the right substitute. 
Altogether, it can be concluded that both the dRGG and zinc-finger mutations have different, 
but severe effects on Mbm localization and function. Future experiments could include ChIP-
seq, RNA-seq or co-immunoprecipitation followed by mass spectrometry to find possible 
binding targets of Mbm. Furthermore, one should investigate flies carrying the mbmdRGG or 
mbmZnF mutation in the wild-type background to see whether there are dominant negative 
effects. 
 
8.2. Mbm is involved in ribosome biogenesis in neuroblasts 
Previously, it was suggested that Mbm affects neuroblast proliferation through a role in 
ribosome biogenesis (Hovhanyan et al., 2014). Thereby, Mbm might be involved in the 
regulation of protein synthesis and since it is transcriptionally regulated by Myc, it might be a 
downstream target of insulin/TOR signaling. The present study provides further insight into 
these proposed roles of Mbm and the importance of its RGG-box therein.  
At first, NB cell size was investigated since it is known to be decreased in mbm null mutants 
(Hovhanyan et al., 2014). It could be shown that NB cell size is also significantly decreased in 
mbmdRGG mutants while cell size is rescued in the mbmSH1819; mbmWT line (Figure 19). Thus, 
re-growth of NBs in mbmdRGG mutants seems to be affected similarly as in mbm null mutants 
providing further hints for the importance of Mbm’s RGG-box. In mbmZnF mutants, in 
contrast, NB size was found not to be affected, which is consistent with the findings of an 
earlier work (Cornelia Engert, Master Thesis, 2015). 
 
8.2.1. Mbm’s RGG-box is important for rRNA binding in vitro 
To investigate a possible role of Mbm in ribosome biogenesis by regulation of rRNA 
processing, rRNA binding assays were performed (Figure 21). This connection was already 
drawn by Hovhanyan et al. (2014) with Northern blots showing an additional intermediate 
rRNA processing product in mbmSH1819 mutants. In the present study, it could be shown that 
Mbm does indeed bind to several rRNA probes in vitro, with the highest binding affinity to 
ITS1. The RGG deleted construct MbmdRGG, in contrast, showed weaker binding to the rRNA 
probes than wild-type Mbm. These results provide further evidence that Mbm is involved in 
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ribosome biogenesis via a role in rRNA processing and that this function might be dependent 
of the RGG-box. However, no other reports of proteins depending on their RGG-box 
specificly for rRNA binding were found. Nucleolin, for example, contains an RGG-box, but 
its binding to rRNA is mediated by other RNA binding domains (Ghisolfi-Nieto et al., 1996; 
Serin et al., 1996; Bouvet et al., 1998). It can therefore not be excluded that the results of this 
in vitro assay are caused by unspecific binding and that Mbm is involved in rRNA processing 
by interaction with another protein in vivo. However, the facts that NB sizes are reduced in 
both the mbmSH1819 and the mbmSH1819; mbmdRGG larvae (Figure 19) and that rRNA processing 
is affected in mbmSH1819 together with the results of the binding assays suggest a role for 
Mbm’s RGG-box in rRNA processing. 
Interestingly, the binding affinity of MbmZnF is increased compared to MbmWT and for the 
double mutant MbmdRGG,ZnF it is increased even further. So far, there is no explanation for this 
other than possible conformational changes of the protein induced by the mutations leading to 
unknown RNA binding motifs to become accessible. If there was an unspecific binding of 
rRNA in the mbmSH1819; mbmZnF mutant larval NBs, this might explain the reduced survival 
rate of larvae even compared to the null mutant mbmSH1819 (Figure 17). However, in larval 
NBs MbmZnF is delocalized to the cytoplasm (Figure 18) and thus should not be able to 
directly influence rRNA processing. On the other hand, it might be possible that MbmZnF 
binds to rRNA in the nucleolus, but does not disassociate again and gets transported to the 
cytoplasm together with the rRNA. However, this would probably impede ribosome assembly 
while protein synthesis rates seem to be even slightly higher in mbmZnF mutant larval brains 
(Figure 26). Furthermore, if MbmZnF bound rRNA in the nucleolus, one would expect at least 
a weak nucleolar signal in the immunostainings, but MbmZnF appears to be fully delocalized 
to the cytoplasm. On the other hand, it is also possible that MbmZnF does not only exhibit a 
higher binding affinity specific to rRNA molecules, but also to mRNAs. MbmZnF might 
therefore interfere with the translation of certain mRNAs, which could also be an explanation 
for the strong effect of the zinc-finger mutation on viability. One possibility to test this 
hypothesis might be an RNA-ChIP followed by RT-PCR and sequencing. Since the target 
sequence for the sequencing primers is unknown, one might be able to make use of the poly T 
tail of the cDNA or try to use short random primer sequences. 
In future experiments, one should try to perform Northern blots again to investigate 
intermediate products of rRNA processing in mbmdRGG and mbmZnF mutants. In the present 
study, Northern blots were attempted, but no distinct bands showing rRNA processing 
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intermediates could be observed. Thus, further optimization of the protocol would be 
necessary in order to be successful. 
 
8.2.2. Mbm is essential for the correct localization of RpS6 
Hovhanyan et al. (2014) could furthermore show a defect in RpS6 localization in mbmSH1819 
mutant larval NBs, which is another hint to Mbm’s implication in ribosome biogenesis. This 
was also investigated in the present study, but while mislocalized RpS6 was found in all three 
mbm mutant lines, the phenotype was the exact opposite of what was reported by Hovhanyan 
et al. (2014). However, the experiments were conducted in a different way: they 
overexpressed an mRFP::RpS6 construct specifically in neuroblasts in wild-type and 
mbmSH1819 background and took images of the autofluorescence of mRFP. In the present 
study, an anti-RpS6 antibody was used for the staining of endogenous RpS6. While 
Hovhanyan et al. (2014) could show cytoplasmic localization of mRFP::RpS6 in the wild-type 
background and mostly nucleolar localization in the mbmSH1819 background, in this study 
RpS6 was found cytoplasmic as well as nucleolar in the wild-type and in the rescue line and 
only cytoplasmic in mbmSH1819,      mbmSH1819; mbmdRGG and mbmSH1819; mbmZnF mutant larval 
NBs (Figure 24). Since ribosomal proteins are synthesized in the cytoplasm and then 
transported into the nucleolus where they are assembled into the pre-ribosomal particles 
(Schlosser et al., 2003; Bohnsack and Bohnsack, 2019), it would make sense to find RpS6 in 
the cytoplasm and in the nucleolus in the wild-type. In this case, RpS6 translocation into the 
nucleolus seems to be defective in NBs of all three mbm mutant lines. In the approach of 
Hovhanyan et al. (2014), localization and assembly into ribosomes may have been disturbed 
by the mRFP-tag, leading to different results. Under this assumption, however, it is interesting 
that the mbm null mutation still has an influence on the localization of mRFP::RpS6. To shed 
light into this, it was attempted to replicate the approach of Hovhanyan et al. (2014) (Figure 
25). However, autofluorescence of mRFP::RpS6 was not sufficient, thus staining with anti-
RFP was tested. mRFP::RpS6 was only found in the cytoplasm in the wild-type as well as the 
mbmSH1819 background while staining with anti-RpS6 revealed the same phenotype as before. 
Whether these different results compared to Hovhanyan et al. (2014) were caused by faulty 
overexpression of mRFP::RpS6 or by unspecific binding of the anti-RFP antibody remains 
elusive. The relatively weak anti-RpS6 staining (Figure 25 A), however, could imply that only 
endogenous RpS6 is expressed or that the RpS6 antibody does not detect mRFP::RpS6. In the 
meantime, however, the experiment was repeated using an anti-mCherry antibody instead of 
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anti-RFP, revealing ambiguous results with some NBs confirming the findings of Hovhanyan 
et al. (2014) and others showing RpS6 localization as found in the present study (personal 
communication: Thomas Raabe). Whether these conflicting results are caused either by 
improper translocation of mRFP::RpS6 or by unspecific binding of the antibodies that were 
used, remains elusive. 
Even though these two experimental approaches regarding the localization of RpS6 in mbm 
null mutant neuroblasts yielded different results, both of them hint to a role of Mbm in RpS6 
translocation. Interestingly, mbmdRGG and mbmZnF mutations seem to influence RpS6 
translocation in the same way as the mbm null mutation, hinting to a loss of function in both 
these mutant lines. This is easier to explain for mbmdRGG, as the RGG-box might be needed 
for the binding of RpS6 or for the interaction with another protein implicated in RpS6 
translocation. Why the same effect is seen in mbmZnF mutants remains elusive. In both 
mutants, protein folding of Mbm might be defective, thereby leading to a (partial) loss of 
function.  
It is important to note, however, that ribosome biogenesis cannot be completely disrupted 
since this would be fatal for the cells. In the fully assembled ribosome, RpS6 is located at the 
interface between the small and large ribosomal subunit and it is suggested to be implicated in 
mRNA and tRNA binding (Nygard and Nika, 1982; Nygard and Nilsson, 1990). Even the 
heterozygous deletion of rps6 leads to a Minute phenotype which includes prolonged 
development, reduced fertility, low viability and short, thin bristles caused by insufficient 
protein synthesis rates (Lambertsson, 1998; Marygold et al., 2007). Thus, RpS6 still has to be 
assembled into ribosomes in the mbm mutants, albeit at possibly lower rates. 
An alternative method to investigate RpS6 localization in NBs of the different Mbm mutant 
lines might be the isolation of the NBs by cell sorting followed by cell fractionation and 
Western blot analysis using the anti-RpS6 antibody. Thereby, one might be able to determine 
the relative RpS6 levels between the nucleolus and the cytoplasm. 
 
8.2.3. Protein synthesis is increased in mbmSH1819; mbmdRGG mutant larval brains 
If ribosome biogenesis was impeded in mbm mutant larval neuroblasts, one would expect a 
change in protein synthesis rates. Therefore, protein synthesis was investigated by puromycin 
labeling of nascent proteins and subsequent Western blotting (Figure 26 and Figure 27). In 
mbmSH1819, the protein synthesis rate is at approximately the same level as in w1118, suggesting 
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that the effect on rRNA processing shown by Hovhanyan et al. (2014) as well as the disturbed 
RpS6 localization do not influence ribosome activity. In the mbmSH1819; mbmZnF and 
mbmSH1819; mbmWT transgenic lines, protein synthesis seems to be roughly doubled, providing 
another hint that some phenotypes may be induced by rescue with genomic mbm constructs 
inserted in the 3rd chromosome in position 65B2. However, protein synthesis in mbmSH1819; 
mbmdRGG larval brains is even further and significantly increased. Thus, there have to be 
additional effects of the mbmdRGG mutation besides the RpS6 delocalization that potentially 
influence ribosome activity. Interestingly, it was shown in mouse embryonic fibroblasts, that 
mutation of RpS6’s phosphorylation sites does not impede its function in the ribosome, but 
even increases protein synthesis rates while the cells are significantly reduced in size 
(Ruvinsky et al., 2005). They also found a small increase in elongation rate, but not to a 
degree that would explain the increase in protein synthesis. The exact mechanism remains 
unknown, but these results suggest a negative regulatory effect of RpS6 phosphorylation on 
protein synthesis (Biever et al., 2015). This raises the question whether RpS6 phosphorylation 
might be reduced in mbmdRGG mutants. RpS6 is phosphorylated by S6K which in turn is 
activated by the TOR signaling pathway (Montagne et al., 1999; Parisi et al., 2011). Could it 
be possible that Mbm plays a role in TOR signaling? On the other hand, it is puzzling, that 
protein synthesis is not increased in mbm null mutant larval brains. Therefore, there might be 
unspecific interactions with proteins, DNA or RNA caused by the RGG deletion. Possibly, 
these interactions can only happen upon nuclear localization of MbmdRGG in contrast to 
cytoplasmic localization of MbmZnF, nucleolar localization of wild-type Mbm or its absence in 
mbm null mutants. 
It is important to note, however, that this approach to investigate protein synthesis does not 
reflect the situation specific for neuroblasts but for the larval brain as a whole. Since NBs are 
very large compared to other cells in the brain, it was assumed that changes in protein 
synthesis induced by mbm mutations might be detectable in whole larval brains. A better 
approach might be the isolation of neuroblasts from the different mbm mutant larval brains by 
cell sorting. Nonetheless, differences between w1118 and the mbmdRGG, mbmZnF and mbmWT 
mutant lines were found. However, the experiment should be conducted several times more to 
improve the possibility of statistical analysis. 
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8.2.4. TOR expression might be increased in mbmSH1819; mbmdRGG mutant larval brains 
Fueled by the results that protein synthesis rates are increased in mbmdRGG mutant larval 
brains and since ribosome biogenesis and thereby protein synthesis is regulated by the 
insulin/TOR pathway (Grewal et al., 2007; Hall et al., 2007), the expression levels of tor, akt 
and s6k genes was investigated by qPCRs (Figure 28). Unfortunately, only three biological 
replicates could be examined. For akt, which is a downstream target in insulin signaling and 
which indirectly activates TOR (reviewed in Grewal, 2009), the results in the three biological 
replicates were highly variable and hardly allow to draw any conclusion. In the case of tor, 
however, expression might be increased in mbmSH1819; mbmdRGG and possibly also in 
mbmSH1819; mbmZnF mutant larval brains, while there is no increase in mbmSH1819 mutants. The 
tor expression levels roughly fit the protein synthesis rates in the different genotypes shown in 
Figure 27. These results further suggest that protein synthesis is indeed increased in mbmdRGG 
mutants even though RpS6 is delocalized and the NB cell size is significantly decreased. 
However, since neither protein synthesis nor tor expression levels are changed in the mbm 
null mutant, the role of the RGG-box remains elusive. Possibly, Mbm’s RGG-box plays a 
regulatory role in ribosome biogenesis, which in the wild-type is only induced in certain 
situations. For example, 4EBP, which is another component of the insulin/TOR pathway, acts 
as metabolic brake only during low nutrient availability (Teleman et al., 2005; Tettweiler et 
al., 2005). Therefore, in certain situations Mbm might act as a promoter of TOR signaling 
mediated by its RGG-box. Since Myc is a downstream target of TOR and Mbm in turn is 
transcriptionally regulated by Myc (Hovhanyan et al., 2014), this might even be a positive 
feedback loop. 
As explained earlier, a decrease in cell size but an increase in protein synthesis rates was 
found in mouse embryonic fibroblasts expressing RpS6 with mutated phosphorylation sites 
(Ruvinsky et al., 2005). This leads to the question whether RpS6 phosphorylation is decreased 
in mbmdRGG mutant larval brains, which might be caused by a decrease in s6k expression or 
activity. However, s6k expression seems to be even increased in mbmSH1819; mbmdRGG larval 
brains (Figure 28 C). Since only three biological replicates were examined and the variability 
between the samples was high, no significant difference was found. Generally, all qPCRs 
should be repeated several times more to increase the chances of finding significant 
differences and to shed more light into the situation. Furthermore, one should try to 
investigate the expression of genes of the TOR pathway on the protein level by Western 
blotting. There are also commercially available phospho-RpS6 antibodies which could be 
used to examine RpS6 phosphorylation levels in the mbm mutant lines. 
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8.3. Mbm might be methylated within its RGG-box 
In earlier studies, arginine methylation in RGG/RG motifs was shown to either promote or 
inhibit protein-protein as well as protein-RNA interactions (Cote and Richard, 2005; Yu et al., 
2004; Blackwell et al., 2010; Wei et al., 2014). Since Mbm binds to rRNA probes through its 
RGG-box in vitro (Figure 21), it was attempted to investigate the methylation status of Mbm 
overexpressed in Drosophila S2R+ cells. The first experiment (Figure 22) showed symmetric 
dimethylation in myc-MbmWT, but no methylation in myc-MbmdRGG. According to these 
results, Mbm is symmetrically dimethylated within its RGG-box. Unfortunately, several 
attempts to replicate these results were not successful, showing no methylation at all. Many 
different experimental conditions were tested to no avail. It is puzzling, why these first results 
appeared so distinct while all further experiments exhibited no methylation. Possibly, arginine 
methylation in S2R+ cells depends on a certain condition, which was met by chance in the 
first experiment.  
Another attempt to elucidate the methylation status of Mbm was done by overexpression of 
His6-tagged Dart1 or Dart5 additionally to myc-Mbm
WT or myc-MbmdRGG. Dart1 and Dart5 
are the most promising candidates for asymmetric and symmetric dimethylation of RGG/RG 
motifs in Drosophila (see 3.3.1.). In the case of successful forced methylation in the S2R+ 
cells, it was furthermore planned to immunoprecipitate the myc-MbmWT and myc-MbmdRGG 
proteins to conduct RNA-binding assays with methylated and unmethylated Mbm. However, 
neither symmetric nor asymmetric methylation of myc-MbmWT and myc-MbmdRGG could be 
observed (Figure 23). Whether this is due to the experimental conditions or to Dart1 and 
Dart5 simply not being able to methylate Mbm, is unknown. It is also possible that the myc- 
and His6-tags interfere with the interaction of the proteins. The SYM11 and ASYM24 
antibodies are widely used to detect arginine methylation and are also known to work well in 
Drosophila (e.g. Kirino et al., 2009). If one would repeat the experiment maybe also including 
other Darts, however, one should think about a positive control that could indicate whether 
the antibodies work properly. Alternatively, one could try to perform in vitro methylation of 
Mbm with radioactive labeling using [3H]AdoMet as a methyl group donor (as described e.g. 
in Nichols et al., 2000). Another possibility would be to investigate the methylation status of 
Mbm by mass spectrometry. However, Mbm’s RGG-box might be methylated by other 
arginine methyltransferases than those used in this study or maybe its function does not rely 
on arginine methylation at all. 
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8.4. Mbm as a neuroblast-specific ribosome biogenesis factor 
Mbm was previously shown to affect RpS6 localization in neuroblasts as well as rRNA 
processing and it was shown to be a transcriptional target of Myc, which suggests an 
involvement of Mbm in the regulation of ribosome biogenesis (Hovhanyan et al., 2014). Even 
though ribosome biogenesis is thought to be a highly conserved process, species- and even 
cell-type specific ribosome biogenesis factors (RBFs) as well as isoforms of ribosomal 
proteins (RPs) or post-translationally modified RPs were found (reviewed in Brombin et al., 
2015). Since no role of Mbm outside of neuroblasts is known so far, Mbm is suggested to be a 
neuroblast-specific ribosome biogenesis factor (RBF) in Drosophila. Specifically in stem 
cells, RBFs are believed to be important for the regulation of differentiation as well as for the 
determination of stem cell identity and stem cell survival (Hayashi et al., 2014; Zhang et al., 
2014; Xue and Barna, 2012; Brombin et al., 2015). 
In the present study, it was attempted to elucidate the molecular basis of Mbm’s functions by 
investigation of its zinc-finger motifs and especially its RGG-box. Some of the results are 
ambiguous, but the effects of the MbmZnF and MbmdRGG mutations on rRNA binding in vitro 
and on RpS6 localization in vivo provide further evidence for Mbm’s suggested role as an 
RBF. Furthermore, protein synthesis rates are increased in mbmdRGG mutants even though NB 
size is significantly reduced. As discussed previously, this seems contradictory, but a similar 
effect was found in mouse embryonic fibroblasts upon mutation of RpS6’s phosphorylation 
sites (Ruvinsky et al., 2005). Therefore, RpS6 phosphorylation levels in the mbmSH1819, 
mbmdRGG and mbmZnF mutants as well as the wild-type should be investigated by Western blot 
analysis or immunofluorescence using phospho-RpS6-specific antibodies. If Mbm was 
involved in RpS6 phosphorylation, this would be another role for Mbm as a ribosome 
biogenesis factor. 
Diseases that are caused by mutations in RBFs, RPs or components of the rRNA transcription 
machinery are called ribosomopathies. In Drosophila, a well known ribosomopathy would be 
the Minute syndrome which is caused by over 60 mutations of RPs (Mills and Green, 2017). 
As discussed previously (see 8.2.2.), even the heterozygous deletion of rps6 leads to a Minute 
phenotype including prolonged development, reduced fertility, low viability and short, thin 
bristles caused by insufficient protein synthesis rates (Lambertsson, 1998; Marygold et al., 
2007). This underscores the importance of RpS6 and of Mbm as a regulator of RpS6 
localization and possibly RpS6 phosphorylation. Many tissue specific ribosomopathies are 
caused by a decrease in protein synthesis rates, which induces upregulation of tumor 
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suppressor p53 and thereby cell cycle arrest and apoptosis (Mills and Green, 2017; Bohnsack 
and Bohnsack, 2019). In the mbm null mutant mbmSH1819, in contrast, protein synthesis rates 
seem to be unchanged and in the mbmdRGG mutant they are significantly increased. 
Furthermore, NBs in these mutants are significantly smaller compared to the wild-type, but 
they do not disappear until late larval stages. Therefore, an involvement of p53 in the 
ribosomopathies caused by the mbm mutations is unlikely. However, in fast-proliferating cell 
types, tissue specific ribosomopathies may also be caused by a reduction of ribosomes and 
thereby a decreased translation rate of specific mRNAs (Bohnsack and Bohnsack, 2019; 
Khajuria et al., 2018). While protein synthesis in the mbm mutants is not decreased, it could 
be possible that alterations of ribosomal proteins cause the ribosomes to favor certain 
mRNAs, thereby leading to insufficient expression of some genes. For example, human 
ribosomes that contain RpS25 and RpL10 were shown to prefer certain mRNAs involved in 
cell cycle and development (Shi et al., 2017; Bohnsack and Bohnsack, 2019). Thus, possible 
posttranslational alterations of RpS6 that might be directly or indirectly mediated by Mbm 
could be important for the the translation of a certain subset of mRNAs. 
So far, the exact causes of the ribosomopathies in the mbmSH1819, mbmdRGG and mbmZnF 
mutants remain unclear, but several results suggest Mbm to be a ribosomal biogenesis factor 
in Drosophila neuroblasts. 
 
8.5. Outlook 
In summary, further evidence was found that Mbm is involved in regulation of ribosome 
biogenesis and NB proliferation. Possibly, some of Mbm’s functions rely on its RGG-box. 
For example, the RGG-box is essential for the binding of rRNA probes in vitro and it might 
also play a role in regulation of the TOR pathway in neuroblasts. However, expression and 
activity levels of genes implicated in the TOR pathway should be further investigated by 
qPCR and Western blot analysis. To see whether rRNA processing is affected in mbmdRGG 
mutants, Northern blots should be performed. Furthermore, one should investigate via Edu-
pulse labeling whether NB progeny number is decreased in mbmdRGG mutants. The zinc-finger 
motifs, on the other hand, do not seem to be important for rRNA binding, but the results are 
puzzling. Since the negative effects in the mbmZnF mutants might be due to faulty protein 
folding and unspecific interactions with other proteins, RNA or DNA, one could try to 
generate new mutants and chose another amino acid substitute for the first cysteine of both 
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zinc-finger motifs. Moreover, it should be investigated in further experiments whether the 
anti-RpS6 antibody specificly detects RpS6 in Drosophila, for example by RNAi knockdown 
of RpS6, which should reduce staining intensity. Furthermore, ribosomal proteins are known 
to fulfill roles outside of ribosomes (reviewed in Zhou et al., 2015). For example, 
phosphorylated RpS6 was shown to inhibit p53-induced tumor suppression in mice (Khalaileh 
et al., 2013). Therefore, it should be investigated whether the phenotypes in the mbm mutant 
lines are caused by ribosome-independent roles of RpS6, possibly in dependence of its 
phosphorylation status. Moreover, one could further examine Mbm’s acidic clusters 1, 2 
and/or 3 to show, for example, whether phosphorylation of Mbm is important for the correct 
localization of RpS6. Furthermore, future experiments could also include investigations to see 
whether type II NB lineages form properly in the different mbm mutants or whether the 
correct neurons are born in their specific time-frame during the temporal series even though 
NB proliferation is negatively affected. 
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&  and 
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%  percent 
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ALH  after larval hatching 
aPKC  atypical protein kinase C 
Ase  Asense 
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CB  central brain 
CFD  cell fate determinants 
CLSM  confocal laser-scanning 
  microscopy 
CNS  central nervous system 
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BSA  bovine serum albumin 
cDNA  complementary 
deoxyribonucleic acid 
cm  centimeter(s) 
DART  Drosophila arginine 
  methyltransferase 
DFC  dense fibrillar component 
dILP2/6 insulin-like peptides 2/6 
Dlg1  Disc Large1 
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dNTP  deoxynucleotide 
triphosphate 
Dpn  Deadpan 
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EDTA  ethylenediaminetetraacetic 
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EGF  epidermal growth factor 
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ETS  external transcribed spacer 
FBS  fetal bovine serum 
FC  fibrillar center 
fwd  forward 
g  gram 
G  glycine 
GC  granular component 
gDNA  genomic deoxyribonucleic 
acid 
GMC  ganglion mother cell 
Grh  Grainyhead 
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h  hour(s) 
Hb  Hunchback 
hnRNP heterogenous nuclear 
  ribonucleoprotein 
IF  immunofluorescence 
INP  intermediate neural 
progenitor 
Insc  Inscutable 
IP  immunoprecipitation 
ITS  internal transcribed spacer 
kb  kilobases 
KOAc  potassium acetate 
Kr  Krüppel 
LBCarb  LB medium containing 100 
  µg/ml carbenicillin 
LD  light dark cycle 
Lgl  Lethal (2) of giant larvae 
MB  mushroom body 
MBNB mushroom body neuroblasts 
Mbm  Mushroom body miniature 
MeOH  methanol 
mg  milligram 
MgCl2  magnesium chloride 
MgSO4 magnesium sulfate 
min  minute(s) 
Mir  Miranda 
µJ  microjoule 
µl  microliter(s) 
ml  milliliter 
mM  millimolar 
µM  micromolar 
NaCl  sodium chloride 
NaIO4  sodium periodate 
NB  neuroblast 
NGS  normal goat serum 
nm  nanometer 
OD600  optical density at a 
wavelength of 600 nm 
OL  optic lobe 
P  proline 
PBS  phosphate buffered saline 
PCR  polymerase chain reaction 
Pins  Partner of Inscuteable 
PntP1  Pointed 
Pol.  polymerase 
PRF  pre-ribosomal factor 
PRMT  protein arginine methyl 
  transferase 
PSU  power supply unit 
R  arginine 
RBF  ribosome biogenesis factor 
rDNA  ribosomal deoxyribonucleic 
  acid 
rev  reverse 
RNA  ribonucleic acid 
RP  ribosomal protein 
RpL11  ribosomal protein L11 
rpm  rounds per minute 
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RpS6  ribosomal protein S6 
rRNA  ribosomal ribonucleic acid 
RT  room temperature 
S  serine 
S6K  S6 kinase 
SDS  sodium dodecyl sulfate 
SFM  serum-free medium
SLIM  site-directed, ligase- 
independent mutagenesis 
snoRNP small nucleolar 
ribonucleoprotein 
TBS  tris buffered saline 
TBS-T  TBS with 0.1 % Tween® 20 
TEMED tetramethylethylenediamine 
TOR  target of rapamycin 
tris  tris(hydroxymethyl)- 
  aminomethane 
VNC  ventral nerve cord 
WB  western blot 
WT  wild-type 
Y  tyrosine 
ZnF  zinc-finger(s) 
 
 
  
